1
|
Rodriguez Martin L, Gilles L, Helte E, Åkesson A, Tägt J, Covaci A, Sakhi AK, Van Nieuwenhuyse A, Katsonouri A, Andersson AM, Gutleb AC, Janasik B, Appenzeller B, Gabriel C, Thomsen C, Mazej D, Sarigiannis D, Anastasi E, Barbone F, Tolonen H, Frederiksen H, Klanova J, Koponen J, Tratnik JS, Pack K, Gudrun K, Ólafsdóttir K, Knudsen LE, Rambaud L, Strumylaite L, Murinova LP, Fabelova L, Riou M, Berglund M, Szabados M, Imboden M, Laeremans M, Eštóková M, Janev Holcer N, Probst-Hensch N, Vodrazkova N, Vogel N, Piler P, Schmidt P, Lange R, Namorado S, Kozepesy S, Szigeti T, Halldorsson TI, Weber T, Jensen TK, Rosolen V, Puklova V, Wasowicz W, Sepai O, Stewart L, Kolossa-Gehring M, Esteban-López M, Castaño A, Bessems J, Schoeters G, Govarts E. Time Patterns in Internal Human Exposure Data to Bisphenols, Phthalates, DINCH, Organophosphate Flame Retardants, Cadmium and Polyaromatic Hydrocarbons in Europe. Toxics 2023; 11:819. [PMID: 37888670 PMCID: PMC10610666 DOI: 10.3390/toxics11100819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 09/21/2023] [Accepted: 09/26/2023] [Indexed: 10/28/2023]
Abstract
Human biomonitoring (HBM) data in Europe are often fragmented and collected in different EU countries and sampling periods. Exposure levels for children and adult women in Europe were evaluated over time. For the period 2000-2010, literature and aggregated data were collected in a harmonized way across studies. Between 2011-2012, biobanked samples from the DEMOCOPHES project were used. For 2014-2021, HBM data were generated within the HBM4EU Aligned Studies. Time patterns on internal exposure were evaluated visually and statistically using the 50th and 90th percentiles (P50/P90) for phthalates/DINCH and organophosphorus flame retardants (OPFRs) in children (5-12 years), and cadmium, bisphenols and polycyclic aromatic hydrocarbons (PAHs) in women (24-52 years). Restricted phthalate metabolites show decreasing patterns for children. Phthalate substitute, DINCH, shows a non-significant increasing pattern. For OPFRs, no trends were statistically significant. For women, BPA shows a clear decreasing pattern, while substitutes BPF and BPS show an increasing pattern coinciding with the BPA restrictions introduced. No clear patterns are observed for PAHs or cadmium. Although the causal relations were not studied as such, exposure levels to chemicals restricted at EU level visually decreased, while the levels for some of their substitutes increased. The results support policy efficacy monitoring and the policy-supportive role played by HBM.
Collapse
Affiliation(s)
- Laura Rodriguez Martin
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Emilie Helte
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Jonas Tägt
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Adrian Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium;
| | - Amrit K. Sakhi
- Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.K.S.); (C.T.)
| | - An Van Nieuwenhuyse
- Laboratoire National de Santé (LNS), Rue Louis Rech 1, 3555 Dudelange, Luxembourg;
| | | | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
- International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), University of Copenhagen, Rigshospitalet, 2100 Copenhagen, Denmark
| | - Arno C. Gutleb
- Luxembourg Institute of Science and Technology (LIST), 4362 Esch-sur-Alzette, Luxembourg;
| | - Beata Janasik
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland; (B.J.); (W.W.)
| | | | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.G.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
| | - Cathrine Thomsen
- Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.K.S.); (C.T.)
| | - Darja Mazej
- Jožef Stefan Institute, 1000 Ljubljana, Slovenia; (D.M.); (J.S.T.)
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.G.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
- Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto–Piazza Della Vittoria 15, 27100 Pavia, Italy
| | - Elena Anastasi
- State General Laboratory, Ministry of Health, 2081 Nicosia, Cyprus; (A.K.); (E.A.)
| | - Fabio Barbone
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy;
| | - Hanna Tolonen
- Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland; (H.T.); (J.K.)
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
| | - Jana Klanova
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 625 00 Brno, Czech Republic; (J.K.); (P.P.)
| | - Jani Koponen
- Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland; (H.T.); (J.K.)
| | | | - Kim Pack
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Koppen Gudrun
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Kristin Ólafsdóttir
- Faculty of Food Science and Nutrition, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland; (K.Ó.); (T.I.H.)
| | - Lisbeth E. Knudsen
- Section of Environmental Health, University of Copenhagen, 1165 Copenhagen, Denmark;
| | - Loïc Rambaud
- Department of Environmental and Occupational Health, Santé Publique France, 94410 Saint Maurice, France (M.R.)
| | - Loreta Strumylaite
- Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania;
| | - Lubica Palkovicova Murinova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 833 03 Bratislava, Slovakia; (L.P.M.)
| | - Lucia Fabelova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 833 03 Bratislava, Slovakia; (L.P.M.)
| | - Margaux Riou
- Department of Environmental and Occupational Health, Santé Publique France, 94410 Saint Maurice, France (M.R.)
| | - Marika Berglund
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Maté Szabados
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Medea Imboden
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland; (M.I.); (N.P.-H.)
| | - Michelle Laeremans
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Milada Eštóková
- Department of Environment and Health, Public Health Authority, 83105 Bratislava, Slovakia;
| | - Natasa Janev Holcer
- Division for Environmental Health, Croatian Institute of Public Health, Rockefellerova 7, 10000 Zagreb, Croatia;
- Department of Social Medicine and Epidemiology, Faculty of Medicine, University of Rijeka, Bráce Branchetta 20/1, 51000 Rijeka, Croatia
| | - Nicole Probst-Hensch
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland; (M.I.); (N.P.-H.)
| | - Nicole Vodrazkova
- Centre for Health and Environment, National Institute of Public Health, 100 00 Prague, Czech Republic; (N.V.); (V.P.)
| | - Nina Vogel
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Pavel Piler
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 625 00 Brno, Czech Republic; (J.K.); (P.P.)
| | - Phillipp Schmidt
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Rosa Lange
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Sónia Namorado
- Department of Epidemiology, National Institute of Health Doctor Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisbon, Portugal;
| | - Szilvia Kozepesy
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Tamás Szigeti
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Thorhallur I. Halldorsson
- Faculty of Food Science and Nutrition, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland; (K.Ó.); (T.I.H.)
| | - Till Weber
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Tina Kold Jensen
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, 5000 Odense, Denmark;
| | - Valentina Rosolen
- Central Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa di Risparmio 10, 34121 Trieste, Italy;
| | - Vladimira Puklova
- Centre for Health and Environment, National Institute of Public Health, 100 00 Prague, Czech Republic; (N.V.); (V.P.)
| | - Wojciech Wasowicz
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland; (B.J.); (W.W.)
| | - Ovnair Sepai
- UKHSA UK Health Security Agency, Harwell Science Park, Chilton OX11 0RQ, UK; (O.S.); (L.S.)
| | - Lorraine Stewart
- UKHSA UK Health Security Agency, Harwell Science Park, Chilton OX11 0RQ, UK; (O.S.); (L.S.)
| | - Marike Kolossa-Gehring
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain; (M.E.-L.); (A.C.)
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain; (M.E.-L.); (A.C.)
| | - Jos Bessems
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium;
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| |
Collapse
|
2
|
Ubong D, Stewart L, Sepai O, Knudsen LE, Berman T, Reynders H, Van Campenhout K, Katsonouri A, Van Nieuwenhuyse A, Ingelido AM, Castaño A, Pedraza-Díaz S, Eiríksdóttir ÁV, Thomsen C, Hartmann C, Gjorgjev D, De Felip E, Tolonen H, Santonen T, Klanova J, Norström K, Kononenko L, Silva MJ, Uhl M, Kolossa-Gehring M, Apel P, Jõemaa M, Jajcaj M, Estokova M, Luijten M, Lebret E, von Goetz N, Holcer NJ, Probst-Hensch N, Cavaleiro R, Barouki R, Tarroja E, Balčienė RM, Strumylaite L, Latvala S, Namorado S, Szigeti T, Ingi Halldorsson T, Olafsdottir K, Wasowicz W. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project. Int J Hyg Environ Health 2023; 251:114170. [PMID: 37207539 DOI: 10.1016/j.ijheh.2023.114170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2022] [Revised: 04/16/2023] [Accepted: 04/17/2023] [Indexed: 05/21/2023]
Abstract
Most countries have acknowledged the importance of assessing and quantifying their population's internal exposure from chemicals in air, water, soil, food and other consumer products due to the potential health and economic impact. Human biomonitoring (HBM) is a valuable tool which can be used to quantify such exposures and effects. Results from HBM studies can also contribute to improving public health by providing evidence of individuals' internal chemical exposure as well as data to understand the burden of disease and associated costs thereby stimulating the development and implementation of evidence-based policy. To have a holistic view on HBM data utilisation, a multi-case research approach was used to explore the use of HBM data to support national chemical regulations, protect public health and raise awareness among countries participating in the HBM4EU project. The Human Biomonitoring for Europe (HBM4EU) Initiative (https://www.hbm4eu.eu/) is a collaborative effort involving 30 countries, the European Environment Agency (EEA) and the European Commission (contracting authority) to harmonise procedures across Europe and advance research into the understanding of the health impacts of environmental chemical exposure. One of the aims of the project was to use HBM data to support evidence based chemical policy and make this information timely and directly available for policy makers and all partners. The main data source for this article was the narratives collected from 27 countries within the HBM4EU project. The countries (self-selection) were grouped into 3 categories in terms of HBM data usage either for public awareness, policy support or for the establishment HBM programme. Narratives were analysed/summarised using guidelines and templates that focused on ministries involved in or advocating for HBM; steps required to engage policy makers; barriers, drivers and opportunities in developing a HBM programme. The narratives reported the use of HBM data either for raising awareness or addressing environmental/public health issues and policy development. The ministries of Health and Environment were reported to be the most prominent entities advocating for HBM, the involvement of several authorities/institutions in the national hubs was also cited to create an avenue to interact, discuss and gain the attention of policy makers. Participating in European projects and the general population interest in HBM studies were seen as drivers and opportunities in developing HBM programmes. A key barrier that was cited by countries for establishing and sustaining national HBM programmes was funding which is mainly due to the high costs associated with the collection and chemical analysis of human samples. Although challenges and barriers still exist, most countries within Europe were already conversant with the benefits and opportunities of HBM. This article offers important insights into factors associated with the utilisation of HBM data for policy support and public awareness.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Dragan Gjorgjev
- Institute of Public Health, Republic of North Macedonia, Macedonia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Vorkamp K, Esteban López M, Gilles L, Göen T, Govarts E, Hajeb P, Katsonouri A, Knudsen LE, Kolossa-Gehring M, Lindh C, Nübler S, Pedraza-Díaz S, Santonen T, Castaño A. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt. Int J Hyg Environ Health 2023; 251:114183. [PMID: 37148759 DOI: 10.1016/j.ijheh.2023.114183] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/08/2023]
Abstract
The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in HBM4EU, addressing the chemical exposure of the general population, temporal developments, occupational exposure and a public health intervention on mercury in populations with high fish consumption. The analyses covered 15 priority groups of organic chemicals and metals and were carried out by a network of laboratories meeting the requirements of a comprehensive quality assurance and control system. The coordination of the chemical analyses included establishing contacts between sample owners and qualified laboratories and monitoring the progress of the chemical analyses during the analytical phase, also addressing status and consequences of Covid-19 measures. Other challenges were related to the novelty and complexity of HBM4EU, including administrative and financial matters and implementation of standardized procedures. Many individual contacts were necessary in the initial phase of HBM4EU. However, there is a potential to develop more streamlined and standardized communication and coordination in the analytical phase of a consolidated European HBM programme.
Collapse
Affiliation(s)
- Katrin Vorkamp
- Aarhus University, Department of Environmental Science, Roskilde, Denmark.
| | - Marta Esteban López
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Thomas Göen
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Parvaneh Hajeb
- Aarhus University, Department of Environmental Science, Roskilde, Denmark
| | | | - Lisbeth E Knudsen
- University of Copenhagen, Institute of Public Health, Copenhagen, Denmark
| | | | - Christian Lindh
- Lund University, Division of Occupational and Environmental Medicine, Lund, Sweden
| | - Stefanie Nübler
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Susana Pedraza-Díaz
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Helsinki, Finland
| | - Argelia Castaño
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| |
Collapse
|
4
|
Vogel N, Lange R, Schmidt P, Rodriguez Martin L, Remy S, Springer A, Puklová V, Černá M, Rudnai P, Középesy S, Janasik B, Ligocka D, Fábelová L, Kolena B, Petrovicova I, Jajcaj M, Eštóková M, Esteban-Lopez M, Castaño A, Tratnik JS, Stajnko A, Knudsen LE, Toppari J, Main KM, Juul A, Andersson AM, Jørgensen N, Frederiksen H, Thomsen C, Sakhi AK, Åkesson A, Hartmann C, Dewolf MC, Koppen G, Biot P, Den Hond E, Voorspoels S, Gilles L, Govarts E, Murawski A, Gerofke A, Weber T, Rüther M, Gutleb AC, Guignard C, Berman T, Koch HM, Kolossa-Gehring M. Exposure to Phthalates in European Children, Adolescents and Adults since 2005: A Harmonized Approach Based on Existing HBM Data in the HBM4EU Initiative. Toxics 2023; 11:241. [PMID: 36977006 PMCID: PMC10057641 DOI: 10.3390/toxics11030241] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 02/10/2023] [Accepted: 02/14/2023] [Indexed: 06/18/2023]
Abstract
Phthalates are mainly used as plasticizers and are associated inter alia with adverse effects on reproductive functions. While more and more national programs in Europe have started monitoring internal exposure to phthalates and its substitute 1,2-Cyclohexanedicarboxylic acid (DINCH), the comparability of results from such existing human biomonitoring (HBM) studies across Europe is challenging. They differ widely in time periods, study samples, degree of geographical coverage, design, analytical methodology, biomarker selection, and analytical quality assurance level. The HBM4EU initiative has gathered existing HBM data of 29 studies from participating countries, covering all European regions and Israel. The data were prepared and aggregated by a harmonized procedure with the aim to describe-as comparably as possible-the EU-wide general population's internal exposure to phthalates from the years 2005 to 2019. Most data were available from Northern (up to 6 studies and up to 13 time points), Western (11; 19), and Eastern Europe (9; 12), e.g., allowing for the investigation of time patterns. While the bandwidth of exposure was generally similar, we still observed regional differences for Butyl benzyl phthalate (BBzP), Di(2-ethylhexyl) phthalate (DEHP), Di-isononyl phthalate (DiNP), and Di-isobutyl phthalate (DiBP) with pronounced decreases over time in Northern and Western Europe, and to a lesser degree in Eastern Europe. Differences between age groups were visible for Di-n-butyl phthalate (DnBP), where children (3 to 5-year olds and 6 to 11-year olds) had lower urinary concentrations than adolescents (12 to 19-year-olds), who in turn had lower urinary concentrations than adults (20 to 39-year-olds). This study is a step towards making internal exposures to phthalates comparable across countries, although standardized data were not available, targeting European data sets harmonized with respect to data formatting and calculation of aggregated data (such as developed within HBM4EU), and highlights further suggestions for improved harmonization in future studies.
Collapse
Affiliation(s)
- Nina Vogel
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Rosa Lange
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | | | - Sylvie Remy
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Andrea Springer
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Vladimíra Puklová
- National Institute of Public Health, Centre for Health and Environment, 10000 Prague, Czech Republic
| | - Milena Černá
- National Institute of Public Health, Centre for Health and Environment, 10000 Prague, Czech Republic
| | - Péter Rudnai
- National Public Health Center, Environmental Health Unit of the Department of Public Health Laboratory, 1097 Budapest, Hungary
| | - Szilvia Középesy
- National Public Health Center, Environmental Health Unit of the Department of Public Health Laboratory, 1097 Budapest, Hungary
| | - Beata Janasik
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland
| | - Danuta Ligocka
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland
| | - Lucia Fábelová
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Branislav Kolena
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 94901 Nitra, Slovakia
| | - Ida Petrovicova
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 94901 Nitra, Slovakia
| | - Michal Jajcaj
- Public Health Authority, Department of Environment and Health, 83105 Bratislava, Slovakia
| | - Milada Eštóková
- Public Health Authority, Department of Environment and Health, 83105 Bratislava, Slovakia
| | | | | | - Janja Snoj Tratnik
- Department of Environmental Sciences, Jožef Stefan Institute, Jamova Cesta 39, 1000 Ljubljana, Slovenia
| | - Anja Stajnko
- Department of Environmental Sciences, Jožef Stefan Institute, Jamova Cesta 39, 1000 Ljubljana, Slovenia
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen, 1165 Copenhagen, Denmark
| | - Jorma Toppari
- Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, 20520 Turku, Finland
- Department of Pediatrics, Turku University Hospital, 20521 Turku, Finland
| | - Katharina M. Main
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
| | - Anders Juul
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
| | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Niels Jørgensen
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Cathrine Thomsen
- Department of Food Safety, Norwegian Institute of Public Health, 0456 Oslo, Norway
| | - Amrit Kaur Sakhi
- Department of Food Safety, Norwegian Institute of Public Health, 0456 Oslo, Norway
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
| | | | | | - Gudrun Koppen
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, 1060 Brussels, Belgium
| | - Elly Den Hond
- Department of Environment and Health, Provincial Institute of Hygiene (PIH), 2000 Antwerp, Belgium
| | - Stefan Voorspoels
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Liese Gilles
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Eva Govarts
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Aline Murawski
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Antje Gerofke
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Till Weber
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Maria Rüther
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Arno C. Gutleb
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology, L-4422 Belvaux, Luxembourg
| | - Cedric Guignard
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology, L-4422 Belvaux, Luxembourg
| | - Tamar Berman
- Department of Environmental Health, Ministry of Health, Jerusalem 9446724, Israel
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany
| | - Marike Kolossa-Gehring
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| |
Collapse
|
5
|
Knudsen LE, Tolonen H, Scheepers PTJ, Loots I, Vorkamp K, Hajeb P, Sepai O, Gilles L, Splanemann P, Weise P, Kolossa-Gehring M. Implementation and coordination of an ethics framework in HBM4EU - Experiences and reflections. Int J Hyg Environ Health 2023; 248:114098. [PMID: 36565602 DOI: 10.1016/j.ijheh.2022.114098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 11/10/2022] [Accepted: 12/02/2022] [Indexed: 12/24/2022]
Abstract
Human biomonitoring involves the use of human samples and data to investigate exposure to environmental chemicals and their impact on human health. HBM4EU developed a coordinated and harmonized approach involving 29 countries in Europe plus Israel. Addressing ethical issues has been an indispensable prerequisite, from the application phase, grant agreement, project performance to the closing of the project. HBM4EU has established a better understanding of the ethics in such projects and the need for a standardised way of reporting and handling of ethics and data exchange, securing compliance with ethics standards, transparency, transferability and sustainability. The main reflections were: KNOWLEDGE: Ethics awareness, norms and practices are dynamic and increased throughout the project, much learning and experience is achieved by practice and dialogue. ATTITUDE Rules and standards were very diversely known and needed to adhere to local practices. ASSISTANCE Good results achieved from webinars, training, help desk, and individual consultations. STANDARDISATION Was achieved by templates and naming convention across documents. MANAGEMENT The establishment of the SharePoint directory with uploading of all requested documents assisted collaboration and exchange. Also, a designated task for ethics within the management/coordination work package and the enthusiasm of the task leader were essential. COMPLIANCE Some, but not all partners were very good at complying with deadlines and standards. TRANSFERABILITY AND SUSTAINABILITY All documents are archived in the SharePoint directory while a system assuring updating is recommended. TRANSPARENCY Assured by public access to annual ethics reports. The ethics reports bridged to the annual work plans (AWPs). EVALUATION The Ethics Check by the Commission was successful.
Collapse
Affiliation(s)
- Lisbeth E Knudsen
- Institute of Public Health, University of Copenhagen, Oester Farimagsgade 5, DK 1353, Copenhagen K, Denmark.
| | - Hanna Tolonen
- Department of Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
| | - Paul T J Scheepers
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, the Netherlands.
| | - Ilse Loots
- Department of Sociology (CRESC) and IMDO, University of Antwerp, Antwerp, Belgium.
| | - Katrin Vorkamp
- Aarhus University, Department of Environmental Science, Frederiksborgvej 399, 4000, Roskilde, Denmark.
| | - Parvaneh Hajeb
- Aarhus University, Department of Environmental Science, Frederiksborgvej 399, 4000, Roskilde, Denmark
| | - Ovnair Sepai
- UK Health Security Agency, Harwell Science Park, OX11 0RQ, UK.
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium.
| | | | | | | |
Collapse
|
6
|
Hammel SC, Andersen HV, Knudsen LE, Frederiksen M. Inhalation and dermal absorption as dominant pathways of PCB exposure for residents of contaminated apartment buildings. Int J Hyg Environ Health 2023; 247:114056. [PMID: 36395656 DOI: 10.1016/j.ijheh.2022.114056] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Revised: 10/13/2022] [Accepted: 10/16/2022] [Indexed: 11/16/2022]
Abstract
Applications of polychlorinated biphenyls (PCBs) in buildings and their persistence in indoor environments have led to cases of current and highly elevated exposure in humans, despite the global cease of production decades ago. Personal exposure to PCBs was assessed among residents in a social housing estate in Denmark containing both contaminated (n = 67) and non-contaminated (n = 23) apartments. Samples and estimated daily intakes (EDIs) were assessed for 15 PCB congeners, and body burden, which was limited by the dietary data availability, was compared across 7 indicator PCBs, with its sum (PCBsum7) often applied in European regulation of PCBs. Median PCBsum7 EDI across measured pathways for exposed residents was 101 ng· (kg bodyweight)-1· day-1, with the majority of exposure (60%) coming from inhalation of contaminated indoor air. Calculated from both PCBs measured in indoor air and on hand wipes, dermal absorption estimates showed comparable results and served as a secondary exposure pathway, accounting for 35% of personal exposure and considering selected assumptions and sources of physical-chemical parameters. Estimates revealed that diet was the primary PCB source among the reference group, accounting for over 75% of the PCBsum7 EDI across exposure routes. When evaluating overall EDIs across the two study groups and including dietary estimates, PCB exposure among exposed residents was around 10 times higher than the reference group. Solely within the exposed population, pathway-specific body burdens were calculated to account for exposure across years of residence in contaminated apartments, where lower chlorinated PCBs were dominant in indoor air. Among these dominant congeners, estimated body burdens of PCB-28 and -52 were significantly correlated with measured serum (rs = 0.49, 0.45; p < 0.001). This study demonstrates that inhalation and dermal absorption serve as dominant exposure pathways for residents of apartments contaminated with predominantly lower chlorinated PCBs and suggest that predictions of body burden from indoor environment measurements may be comparable to measured serum PCBs.
Collapse
Affiliation(s)
- Stephanie C Hammel
- National Research Centre for the Working Environment, Lersø Parkallé 105, 2100, Copenhagen Ø, Denmark.
| | - Helle Vibeke Andersen
- Department of the Built Environment, Aalborg University, A.C. Meyers Vænge 15, 2400, Copenhagen SV, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 1014, Copenhagen K, Denmark
| | - Marie Frederiksen
- National Research Centre for the Working Environment, Lersø Parkallé 105, 2100, Copenhagen Ø, Denmark
| |
Collapse
|
7
|
Gerofke A, David M, Schmidt P, Vicente JL, Buekers J, Gilles L, Colles A, Bessems J, Bastiaensen M, Covaci A, Den Hond E, Koppen G, Laeremans M, Verheyen VJ, Černá M, Klánová J, Krsková A, Zvonař M, Knudsen LE, Koch HM, Jensen TK, Rambaud L, Riou M, Vogel N, Gabriel C, Karakitsios S, Papaioannou N, Sarigiannis D, Kakucs R, Középesy S, Rudnai P, Szigeti T, Barbone F, Rosolen V, Guignard C, Gutleb AC, Sakhi AK, Haug LS, Janasik B, Ligocka D, Estokova M, Fabelova L, Kolena B, Murinova LP, Petrovicova I, Richterova D, Horvat M, Mazej D, Tratnik JS, Runkel AA, Castaño A, Esteban-López M, Pedraza-Díaz S, Åkesson A, Lignell S, Vlaanderen J, Zock JP, Schoeters G, Kolossa-Gehring M. From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure. Int J Hyg Environ Health 2023; 247:114073. [PMID: 36434900 PMCID: PMC9758616 DOI: 10.1016/j.ijheh.2022.114073] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 10/19/2022] [Accepted: 11/07/2022] [Indexed: 11/25/2022]
Abstract
Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.
Collapse
Affiliation(s)
- Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany,Corresponding author.
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Joana Lobo Vicente
- European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen, Denmark
| | - Jurgen Buekers
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Liese Gilles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Ann Colles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Jos Bessems
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | | - Adrian Covaci
- Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium
| | | | - Gudrun Koppen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Michelle Laeremans
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Veerle J. Verheyen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Milena Černá
- National Institute of Public Health, Prague, Czech Republic
| | - Jana Klánová
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Andrea Krsková
- National Institute of Public Health, Prague, Czech Republic
| | - Martin Zvonař
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic,Faculty of Sport Studies, Masaryk University, Kamenice 753/5, Brno, Czech Republic
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen Øster Farimagsgade 5 DK Copenhagen, Denmark
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance − Institute of the Ruhr University Bochum (IPA), 44789, Bochum, Germany
| | - Tina Kold Jensen
- Faculty of Health Sciences, Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - Loïc Rambaud
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Margaux Riou
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Nina Vogel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Nafsika Papaioannou
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece,Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto - Piazza Della Vittoria 15, 27100, Pavia, Italy
| | - Réka Kakucs
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Szilvia Középesy
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Péter Rudnai
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Tamás Szigeti
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100, Udine, Italy
| | - Valentina Rosolen
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137, Trieste, Italy
| | - Cedric Guignard
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | - Arno C. Gutleb
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | | | | | - Beata Janasik
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Danuta Ligocka
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Milada Estokova
- Public Health Authority of the Slovak Republic, Trnavska cesta 52, 826 45, Bratislava, Slovakia
| | - Lucia Fabelova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Branislav Kolena
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | | | - Ida Petrovicova
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | - Denisa Richterova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Milena Horvat
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Darja Mazej
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Janja Snoj Tratnik
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Agneta Annika Runkel
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Susana Pedraza-Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Sanna Lignell
- Swedish Food Agency, PO Box 622, SE-751 26, Uppsala, Sweden
| | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - Jan-Paul Zock
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | |
Collapse
|
8
|
Neuhaus W, Reininger-Gutmann B, Rinner B, Plasenzotti R, Wilflingseder D, De Kock J, Vanhaecke T, Rogiers V, Jírová D, Kejlová K, Knudsen LE, Nielsen RN, Kleuser B, Kral V, Thöne-Reineke C, Hartung T, Pallocca G, Rovida C, Leist M, Hippenstiel S, Lang A, Retter I, Krämer S, Jedlicka P, Ameli K, Fritsche E, Tigges J, Kuchovská E, Buettner M, Bleich A, Baumgart N, Baumgart J, Meinhardt MW, Spanagel R, Chourbaji S, Kränzlin B, Seeger B, von Köckritz-Blickwede M, Sánchez-Morgado JM, Galligioni V, Ruiz-Pérez D, Movia D, Prina-Mello A, Ahluwalia A, Chiono V, Gutleb AC, Schmit M, van Golen B, van Weereld L, Kienhuis A, van Oort E, van der Valk J, Smith A, Roszak J, Stępnik M, Sobańska Z, Reszka E, Olsson IAS, Franco NH, Sevastre B, Kandarova H, Capdevila S, Johansson J, Svensk E, Cederroth CR, Sandström J, Ragan I, Bubalo N, Kurreck J, Spielmann H. The Current Status and Work of Three Rs Centres and Platforms in Europe. Altern Lab Anim 2022; 50:381-413. [PMID: 36458800 DOI: 10.1177/02611929221140909] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
The adoption of Directive 2010/63/EU on the protection of animals used for scientific purposes has given a major push to the formation of Three Rs initiatives in the form of centres and platforms. These centres and platforms are dedicated to the so-called Three Rs, which are the Replacement, Reduction and Refinement of animal use in experiments. ATLA's 50th Anniversary year has seen the publication of two articles on European Three Rs centres and platforms. The first of these was about the progressive rise in their numbers and about their founding history; this second part focuses on their current status and activities. This article takes a closer look at their financial and organisational structures, describes their Three Rs focus and core activities (dissemination, education, implementation, scientific quality/translatability, ethics), and presents their areas of responsibility and projects in detail. This overview of the work and diverse structures of the Three Rs centres and platforms is not only intended to bring them closer to the reader, but also to provide role models and show examples of how such Three Rs centres and platforms could be made sustainable. The Three Rs centres and platforms are very important focal points and play an immense role as facilitators of Directive 2010/63/EU 'on the ground' in their respective countries. They are also invaluable for the wide dissemination of information and for promoting the implementation of the Three Rs in general.
Collapse
Affiliation(s)
- Winfried Neuhaus
- EUSAAT, 31189Austrian Institute of Technology (AIT) GmbH, Competence Unit Molecular Diagnostics, Centre for Health and Bioresources, Vienna, Austria, and Danube Private University, Department of Medicine, Krems, Austria
| | | | - Beate Rinner
- Biomedical Research, 31475Medical University Graz, Austria
| | - Roberto Plasenzotti
- Department of Biomedical Research, 27271Medical University of Vienna, Austria
| | - Doris Wilflingseder
- 27255Institute of Hygiene and Medical Microbiology Medical University of Innsbruck, Austria
| | - Joery De Kock
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Tamara Vanhaecke
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Vera Rogiers
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Dagmar Jírová
- Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic
| | - Kristina Kejlová
- Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic
| | | | | | - Burkhard Kleuser
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| | - Vivian Kral
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| | - Christa Thöne-Reineke
- 9166Freie Universität Berlin, Department of Veterinary Medicine, Institute of Animal Welfare, Animal Behaviour and Laboratory Animal Science, Berlin, Germany
| | - Thomas Hartung
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Giorgia Pallocca
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Costanza Rovida
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Marcel Leist
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Stefan Hippenstiel
- 14903Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Annemarie Lang
- 14903Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Ida Retter
- 14903Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Stephanie Krämer
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Peter Jedlicka
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Katharina Ameli
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Ellen Fritsche
- 256593IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany
- Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | - Julia Tigges
- 256593IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany
| | - Eliška Kuchovská
- 256593IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany
| | - Manuela Buettner
- Institute for Laboratory Animal Science, 9177Hannover Medical School, Hannover, Germany
| | - Andre Bleich
- Institute for Laboratory Animal Science, 9177Hannover Medical School, Hannover, Germany
| | - Nadine Baumgart
- TARC force 3R, Translational Animal Research Center, University Medical Centre, Johannes Gutenberg-University Mainz, Germany
| | - Jan Baumgart
- Translational Animal Research Center, University Medical Centre, Johannes Gutenberg-University Mainz, Germany
| | - Marcus W Meinhardt
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Rainer Spanagel
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Sabine Chourbaji
- Interfaculty Biomedical Research Facility (IBF), University Heidelberg, Heidelberg, Germany
| | - Bettina Kränzlin
- Core Facility Preclinical Models, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Bettina Seeger
- 460510University of Veterinary Medicine Hannover, Institute for Food Quality and Food Safety, Research Group Food Toxicology and Alternatives/Complementary Methods to Animal Experiments, Hannover, Germany
| | - Maren von Köckritz-Blickwede
- 460510University of Veterinary Medicine Hannover, Department of Biochemistry & Research Centre for Emerging Infections and Zoonoses, Hannover, Germany
| | | | - Viola Galligioni
- Bioresearch and Veterinary Services, The University of Edinburgh, Edinburgh, UK
| | - Daniel Ruiz-Pérez
- Bioresearch and Veterinary Services, The University of Edinburgh, Edinburgh, UK
| | - Dania Movia
- Comparative Medicine Unit, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Adriele Prina-Mello
- Comparative Medicine Unit, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Arti Ahluwalia
- Applied Radiation Therapy Trinity (ARTT) and Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), School of Medicine, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Valeria Chiono
- Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), School of Medicine, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Arno C Gutleb
- Department of Information Engineering, Università di Pisa and Centro 3R, Interuniversity Centre for the Promotion of 3Rs Principles in Teaching and Research, Italy
| | - Marthe Schmit
- Department of Mechanical and Aerospace Engineering, 19032Politecnico di Torino, Torino and Centro 3R, and Interuniversity Center for the Promotion of 3Rs Principles in Teaching and Research, Italy
| | - Bea van Golen
- Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | | | - Anne Kienhuis
- 2890Ministry of Agriculture, Nature and Food Quality, The Hague, The Netherlands
| | - Erica van Oort
- Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | - Jan van der Valk
- Netherlands National Committee for the protection of animals used for scientific purposes (NCad), The Hague, The Netherlands
| | - Adrian Smith
- National Institute for Public Health and the Environment-RIVM, BA Bilthoven, The Netherlands
| | - Joanna Roszak
- 3Rs-Centre, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
| | - Maciej Stępnik
- 3Rs-Centre, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
- Norecopa, Ås, Norway
| | - Zuzanna Sobańska
- 3Rs-Centre, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
| | - Edyta Reszka
- 3Rs-Centre, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
| | - I Anna S Olsson
- The National Centre for Alternative Methods to Toxicity Assessment, 49611Nofer Institute of Occupational Medicine, Łódź, Poland
- QSAR Lab Ltd, Gdańsk, Poland
| | - Nuno Henrique Franco
- The National Centre for Alternative Methods to Toxicity Assessment, 49611Nofer Institute of Occupational Medicine, Łódź, Poland
- QSAR Lab Ltd, Gdańsk, Poland
| | - Bogdan Sevastre
- IBMC-Instituto de Biologia Molecular e Celular, 26706Universidade do Porto, Porto, Portugal
| | - Helena Kandarova
- i3S-Instituto de Investigação e Inovação em Saúde, 26706Universidade do Porto, Porto, Portugal
| | - Sara Capdevila
- Romanian Center for Alternative Test Methods (ROCAM) hosted by the 162275University of Agricultural Sciences and Veterinary Medicine in Cluj-Napoca, Romania
| | - Jessica Johansson
- Slovak National Platform for 3Rs-SNP3Rs, Bratislava, Slovakia; and Department of Tissue Cultures and Biochemical Engineering, Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, 87171Slovak Academy of Sciences, Bratislava, Slovakia
| | - Emma Svensk
- Slovak National Platform for 3Rs-SNP3Rs, Bratislava, Slovakia; and Department of Tissue Cultures and Biochemical Engineering, Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, 87171Slovak Academy of Sciences, Bratislava, Slovakia
| | - Christopher R Cederroth
- Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
| | - Jenny Sandström
- Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
| | - Ian Ragan
- Swedish 3Rs Center, Swedish Board of Agriculture, Jönköping, Sweden
| | | | - Jens Kurreck
- National Centre for the 3Rs (NC3Rs), London, United Kingdom
| | - Horst Spielmann
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| |
Collapse
|
9
|
Frederiksen M, Andersen HV, Ovesen SL, Vorkamp K, Hammel SC, Knudsen LE. Silicone wristbands as personal passive samplers of exposure to polychlorinated biphenyls in contaminated buildings. Environ Int 2022; 167:107397. [PMID: 35933843 DOI: 10.1016/j.envint.2022.107397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 06/30/2022] [Accepted: 07/05/2022] [Indexed: 06/15/2023]
Abstract
Polychlorinated biphenyls (PCBs) were used in a number of industrial products from 1950 to 80s, including building materials. As a result, some buildings exhibit high levels of PCBs in the indoor environment. The aim of this study was to test silicone wristbands as a method for estimating personal exposure to PCBs in buildings both in controlled experiments and field settings. In the controlled study, the sampling kinetics of silicone wristbands were investigated in a 31-day uptake study. The field study focused on the application of wristbands as a personal exposure measure. It included 71 persons in a contaminated housing estate and 23 persons in a reference group. The linear uptake of PCBs ranged from 2 to 24 days for PCB-8, 18, 28, 31, 40, 44, 49, 52, 66, 99, and 101 under controlled conditions. A generic sampling rate (Rk) of 2.3 m3 d-1 corresponding to a mass transfer coefficient of 17 m h-1 was found in the controlled kinetic study. Partitioning coefficients were also determined for the nine congeners. In the field study, an apparent generic field sampling rate (Rf) of 2.6 m3 d-1 was found; when adjusted to reported hours exposed, it increased to 3.5 m3 d-1. The wristbands were shown to be a good tool for predicting airborne exposure, as there was a highly significant difference between the exposed and reference group as well as a clear trend when used for ranking of exposure. In correlation analyses, highly significant correlations were observed between air and wristband levels, though adjusting by self-reported exposure time only increased the correlation marginally in the field study. The obtained kinetic data can be used for estimating the magnitude of external exposure. The advantages provided by the wristbands in the form of easy use and handling are significant, though the limitations should also be acknowledged.
Collapse
Affiliation(s)
- Marie Frederiksen
- National Research Centre for the Working Environment, Lersø Parkalle 105, 2100 Copenhagen Ø, Denmark.
| | - Helle Vibeke Andersen
- Department of the Built Environment, Aalborg University, A.C. Meyers Vænge 15, 2400 Copenhagen SV, Denmark
| | - Sofie Lillelund Ovesen
- National Research Centre for the Working Environment, Lersø Parkalle 105, 2100 Copenhagen Ø, Denmark
| | - Katrin Vorkamp
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, 4000 Roskilde, Denmark
| | - Stephanie C Hammel
- National Research Centre for the Working Environment, Lersø Parkalle 105, 2100 Copenhagen Ø, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 1014 Copenhagen K, Denmark
| |
Collapse
|
10
|
Neuhaus W, Reininger-Gutmann B, Rinner B, Plasenzotti R, Wilflingseder D, De Kock J, Vanhaecke T, Rogiers V, Jírová D, Kejlová K, Knudsen LE, Nielsen RN, Kleuser B, Kral V, Thöne-Reineke C, Hartung T, Pallocca G, Leist M, Hippenstiel S, Lang A, Retter I, Krämer S, Jedlicka P, Ameli K, Fritsche E, Tigges J, Buettner M, Bleich A, Baumgart N, Baumgart J, Meinhardt MW, Spanagel R, Chourbaji S, Kränzlin B, Seeger B, von Köckritz-Blickwede M, Sánchez-Morgado JM, Galligioni V, Ruiz-Pérez D, Movia D, Prina-Mello A, Ahluwalia A, Chiono V, Gutleb AC, Schmit M, van Golen B, van Weereld L, Kienhuis A, van Oort E, van der Valk J, Smith A, Roszak J, Stępnik M, Sobańska Z, Olsson IAS, Franco NH, Sevastre B, Kandarova H, Capdevila S, Johansson J, Cederroth CR, Sandström J, Ragan I, Bubalo N, Spielmann H. The Rise of Three Rs Centres and Platforms in Europe. Altern Lab Anim 2022; 50:90-120. [PMID: 35578444 DOI: 10.1177/02611929221099165] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Public awareness and discussion about animal experiments and replacement methods has greatly increased in recent years. The term 'the Three Rs', which stands for the Replacement, Reduction and Refinement of animal experiments, is inseparably linked in this context. A common goal within the Three Rs scientific community is to develop predictive non-animal models and to better integrate all available data from in vitro, in silico and omics technologies into regulatory decision-making processes regarding, for example, the toxicity of chemicals, drugs or food ingredients. In addition, it is a general concern to implement (human) non-animal methods in basic research. Toward these efforts, there has been an ever-increasing number of Three Rs centres and platforms established over recent years - not only to develop novel methods, but also to disseminate knowledge and help to implement the Three Rs principles in policies and education. The adoption of Directive 2010/63/EU on the protection of animals used for scientific purposes gave a strong impetus to the creation of Three Rs initiatives, in the form of centres and platforms. As the first of a series of papers, this article gives an overview of the European Three Rs centres and platforms, and their historical development. The subsequent articles, to be published over the course of ATLA's 50th Anniversary year, will summarise the current focus and tasks as well as the future and the plans of the Three Rs centres and platforms. The Three Rs centres and platforms are very important points of contact and play an immense role in their respective countries as 'on the ground' facilitators of Directive 2010/63/EU. They are also invaluable for the widespread dissemination of information and for promoting implementation of the Three Rs in general.
Collapse
Affiliation(s)
- Winfried Neuhaus
- EUSAAT and Austrian Institute of Technology (AIT) GmbH, Competence Unit Molecular Diagnostics, Centre for Health and Bioresources, Vienna, Austria
| | | | - Beate Rinner
- Biomedical Research, 31475Medical University Graz, Austria
| | - Roberto Plasenzotti
- Department of Biomedical Research, 27271Medical University of Vienna, Austria
| | - Doris Wilflingseder
- Institute of Hygiene and Medical Microbiology, 27280Medical University of Innsbruck, Austria
| | - Joery De Kock
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Tamara Vanhaecke
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Vera Rogiers
- 70493Vrije Universiteit Brussel (VUB), Innovation Centre-3R Alternatives (IC-3Rs), Dept. In Vitro Toxicology and Dermato-Cosmetology (IVTD), Brussels, Belgium
| | - Dagmar Jírová
- Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic
| | - Kristina Kejlová
- Centre of Toxicology and Health Safety, 37739National Institute of Public Health, Prague, Czech Republic
| | | | | | - Burkhard Kleuser
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| | - Vivian Kral
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| | - Christa Thöne-Reineke
- 9166Freie Universität Berlin, Department of Veterinary Medicine, Institute of Animal Welfare, Animal Behaviour and Laboratory Animal Science, Berlin, Germany
| | - Thomas Hartung
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Giorgia Pallocca
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Marcel Leist
- Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Germany
| | - Stefan Hippenstiel
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Annemarie Lang
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Ida Retter
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité3R, Berlin, Germany
| | - Stephanie Krämer
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Peter Jedlicka
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Katharina Ameli
- 3R Centre JLU Giessen, Interdisciplinary Centre for 3Rs in Animal Research (ICAR3R), Giessen, Germany
| | - Ellen Fritsche
- IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.,Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | - Julia Tigges
- IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany
| | - Manuela Buettner
- Institute for Laboratory Animal Science, 9177Hannover Medical School, Hannover, Germany
| | - Andre Bleich
- Institute for Laboratory Animal Science, 9177Hannover Medical School, Hannover, Germany
| | - Nadine Baumgart
- TARC force 3R, Translational Animal Research Center, University Medical Centre, Johannes Gutenberg-University Mainz, Germany
| | - Jan Baumgart
- Translational Animal Research Center, University Medical Centre, Johannes Gutenberg-University Mainz, Germany
| | - Marcus W Meinhardt
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Rainer Spanagel
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Sabine Chourbaji
- Interfaculty Biomedical Research Facility (IBF), University Heidelberg, Heidelberg, Germany
| | - Bettina Kränzlin
- Medical Research Centre, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Bettina Seeger
- 460510University of Veterinary Medicine Hannover, Institute for Food Quality and Food Safety, Research Group Food Toxicology and Alternatives/Complementary Methods to Animal Experiments, Hannover, Germany
| | - Maren von Köckritz-Blickwede
- 460510University of Veterinary Medicine Hannover, Department of Biochemistry & Research Centre for Emerging Infections and Zoonoses, Hannover, Germany
| | | | - Viola Galligioni
- Comparative Medicine Unit, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Daniel Ruiz-Pérez
- Comparative Medicine Unit, 8809Trinity College Dublin, College Green, Dublin, Ireland
| | - Dania Movia
- Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), School of Medicine, 460510Trinity College Dublin, College Green, Dublin, Ireland
| | - Adriele Prina-Mello
- Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), School of Medicine, 460510Trinity College Dublin, College Green, Dublin, Ireland
| | - Arti Ahluwalia
- Department of Information Engineering, Universita' di Pisa and Centro 3R, Interuniversity Centre for the Promotion of 3Rs Principles in Teaching and Research, Italy
| | - Valeria Chiono
- Department of Mechanical and Aerospace Engineering, 19032Politecnico di Torino, Torino and Centro 3R, and Interuniversity Center for the Promotion of 3Rs Principles in Teaching and Research, Italy
| | - Arno C Gutleb
- Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | - Marthe Schmit
- 81872University of Luxembourg, Esch-sur-Alzette, Luxembourg
| | - Bea van Golen
- 2890Ministry of Agriculture, Nature and Food Quality, The Hague, The Netherlands
| | - Leane van Weereld
- Netherlands National Committee for the protection of animals used for scientific purposes (NCad), The Hague, The Netherlands
| | - Anne Kienhuis
- National Institute for Public Health and the Environment-RIVM, BA Bilthoven, The Netherlands
| | - Erica van Oort
- 2890Ministry of Agriculture, Nature and Food Quality, The Hague, The Netherlands
| | - Jan van der Valk
- 3Rs-Centre, Department of Population Health Sciences, Faculty of Veterinary Medicine, 8125Utrecht University, Utrecht, The Netherlands
| | - Adrian Smith
- Norecopa ℅ Norwegian Veterinary Institute, Ås, Norway
| | - Joanna Roszak
- The National Centre for Alternative Methods to Toxicity Assessment, 49611Nofer Institute of Occupational Medicine, Łódź, Poland
| | - Maciej Stępnik
- The National Centre for Alternative Methods to Toxicity Assessment, 49611Nofer Institute of Occupational Medicine, Łódź, Poland.,QSAR Lab Ltd, Gdańsk, Poland
| | - Zuzanna Sobańska
- The National Centre for Alternative Methods to Toxicity Assessment, 49611Nofer Institute of Occupational Medicine, Łódź, Poland
| | - I Anna S Olsson
- IBMC-Instituto de Biologia Molecular e Celular, 26706Universidade do Porto, Porto, Portugal.,i3S-Instituto de Investigação e Inovação em Saúde, 26706Universidade do Porto, Porto, Portugal
| | - Nuno Henrique Franco
- IBMC-Instituto de Biologia Molecular e Celular, 26706Universidade do Porto, Porto, Portugal.,i3S-Instituto de Investigação e Inovação em Saúde, 26706Universidade do Porto, Porto, Portugal
| | - Bogdan Sevastre
- Romanian Center for Alternative Test Methods (ROCAM) hosted by the 162275University of Agricultural Sciences and Veterinary Medicine in Cluj-Napoca, Romania
| | - Helena Kandarova
- Slovak National Platform for 3Rs-SNP3Rs, Bratislava, Slovakia; and Department of Tissue Cultures and Biochemical Engineering, Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS, 87171Slovak Academy of Sciences, Bratislava, Slovakia
| | - Sara Capdevila
- Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
| | | | | | | | - Ian Ragan
- National Centre for the 3Rs (NC3Rs), London, United Kingdom
| | - Nataliia Bubalo
- 243563The National University of Food Technologies, Department of Fats, Perfumery and Cosmetic Products Technology, Kyiv, Ukraine
| | - Horst Spielmann
- 9166Freie Universität Berlin, Institute of Pharmacy, Pharmacology and Toxicology, Berlin, Germany
| |
Collapse
|
11
|
Tolonen H, Moore S, Lermen D, Virgolino A, Knudsen LE, Andersson AM, Rambaud L, Ancona C, Kolossa-Gehring M. What is required to combine human biomonitoring and health surveys? Int J Hyg Environ Health 2022; 242:113964. [DOI: 10.1016/j.ijheh.2022.113964] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 03/16/2022] [Accepted: 03/22/2022] [Indexed: 12/17/2022]
|
12
|
Andersen MHG, Zuri G, Knudsen LE, Mathiesen L. Placental transport of parabens studied using an ex-vivo human perfusion model. Placenta 2021; 115:121-128. [PMID: 34601208 DOI: 10.1016/j.placenta.2021.09.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 08/16/2021] [Accepted: 09/02/2021] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Parabens are a group of chemicals widely used as preservatives in daily consumer products such as cosmetics, food items, pharmaceuticals and household commodities. They have been broadly detected in human samples indicating a general human exposure, and concerns arose from their potential endocrine disrupting effect. Especially the exposure to parabens during pregnancy is concerning, as the time of fetal development is a particularly vulnerable period. The aim of this study was to investigate the transport and metabolism of four commonly used parabens: methyl-, ethyl-, propyl- and butylparaben (MeP, EtP, PrP and BuP) and the metabolite para-hydroxybenzoic acid (PHBA) across the human placenta. METHODS An ex-vivo human placental perfusion model was used. The test compounds were added in the maternal compartment (with initial concentrations of 1 mM or 0.1 mM). Placental transport was evaluated by fetal-maternal concentration ratios (FM-ratio), transport index (TI) and indicative permeability (IP). RESULTS Information about parabens kinetics was taken from 10 perfusions and PHBA from 7 perfusions. Paraben metabolism was not detected. The placental transport of MeP, EtP, PrP, BuP and PHBA revealed a transfer from maternal to fetal circulations with FM120 of 0.86 ± 0.27 (MeP), 0.98 ± 0.28 (EtP), 1.00 ± 0.28 (PrP), 1.12 ± 0.59 (BuP) and 0.82 ± 0.37 (PHBA). The test substances accumulated in the perfused tissue in some degree. The average kinetic parameters FM-ratio, TI and IP were not different between chemicals. DISCUSSION The present study shows that the placenta barrier is permeable to all four parabens and the metabolite, which implies potential fetal exposure.
Collapse
Affiliation(s)
- Maria Helena Guerra Andersen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014, Copenhagen K, Denmark; The National Research Centre for the Working Environment, Lersø Parkalle 105, DK-1014, Copenhagen Ø, Denmark
| | - Giuseppina Zuri
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014, Copenhagen K, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014, Copenhagen K, Denmark
| | - Line Mathiesen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014, Copenhagen K, Denmark.
| |
Collapse
|
13
|
Gilles L, Govarts E, Rambaud L, Vogel N, Castaño A, Esteban López M, Rodriguez Martin L, Koppen G, Remy S, Vrijheid M, Montazeri P, Birks L, Sepai O, Stewart L, Fiddicke U, Loots I, Knudsen LE, Kolossa-Gehring M, Schoeters G. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey. Int J Hyg Environ Health 2021; 237:113809. [PMID: 34455198 PMCID: PMC8504197 DOI: 10.1016/j.ijheh.2021.113809] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 07/12/2021] [Accepted: 07/14/2021] [Indexed: 10/26/2022]
Abstract
As part of the Human Biomonitoring for Europe (HBM4EU) initiative a human biomonitoring (HBM) survey is conducted in 21 countries. This survey builds on existing HBM capacity in Europe by aligning national or regional HBM studies. The survey targets 3 age groups (i) children aged 6-11 years, (ii) teenagers aged 12-19 years and (iii) young adults aged 20-39 years and includes a total of 9493 participants (3151 children, 2953 teenagers and 3389 young adults). Depending on the age group, internal exposure to phthalates and substitute Hexamoll® DINCH, brominated and organophosphorus flame retardants, per-/poly-fluorinated compounds, cadmium, bisphenols and/or polycyclic aromatic hydrocarbons are assessed. The main goal of the programme is to obtain quality controlled and comparable HBM data of exposure to chemicals, prioritized under HBM4EU, with European wide coverage to inform the development of environment and health policies. This paper describes the framework of the HBM4EU survey and the approach that has been applied to align European HBM initiatives across Europe.
Collapse
Affiliation(s)
- Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Loïc Rambaud
- Santé Publique France, French Public Health Agency (ANSP), Saint-Maurice, France
| | - Nina Vogel
- German Environment Agency (UBA), Berlin, Germany
| | - Argelia Castaño
- National Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Marta Esteban López
- National Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | | | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Sylvie Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Martine Vrijheid
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Parisa Montazeri
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Laura Birks
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
| | | | | | | | - Ilse Loots
- Department of Sociology (CRESC) and IMDO, University of Antwerp, Antwerp, Belgium
| | | | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; University of Southern Denmark, Institute of Public Health, Department of Environmental Medicine, Odense, Denmark
| |
Collapse
|
14
|
Nathan NO, Hedegaard M, Karlsson G, Knudsen LE, Mathiesen L. Intrapartum transfer of oxytocin across the human placenta: An ex vivo perfusion experiment. Placenta 2021; 112:105-110. [PMID: 34329968 DOI: 10.1016/j.placenta.2021.07.289] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 05/24/2021] [Accepted: 07/19/2021] [Indexed: 11/26/2022]
Abstract
INTRODUCTION Investigation of the maternal to fetal transfer of oxytocin across the dually perfused term human placenta. METHODS Human placentae obtained from term singleton pregnancies were utilized in a dual recirculating model of ex vivo placental perfusion. Six placentae from women delivering by elective cesarean at term were perfused, one blank and five with the test substance synthetic oxytocin (0.8 ng/mL) (OX) added to the maternal perfusate for 180 min. Antipyrine was used as positive control to validate overlap of the maternal and fetal circuits. The concentration of OX was determined by radioimmunoassay. RESULTS A fall in maternal concentration of OX was seen throughout the experiment. At 90 min of perfusion a state of equilibrium was reached between maternal and fetal concentrations; however after 180 min the fetal concentration of OX was higher than that of the maternal. 31 % of the test substance was accounted for at the end of the experiment - suggesting OX protein binding and a high degree of oxytocinase activity. DISCUSSION The ex vivo perfusion experiments revealed low transfer of OX to the fetal circuit below physiologically relevant concentrations.
Collapse
Affiliation(s)
- Nina Olsén Nathan
- The Research Unit Women's and Children's Health, The Juliane Marie Centre for Women, Children and Reproduction, Copenhagen University Hospital, Rigshospitalet, Tagensvej 22, 2200, Copenhagen, Denmark; Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark
| | - Morten Hedegaard
- Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark
| | - Gösta Karlsson
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
| | - Lisbeth E Knudsen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, Building 9, 1014, Copenhagen, Denmark
| | - Line Mathiesen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, Building 9, 1014, Copenhagen, Denmark.
| |
Collapse
|
15
|
Fenech M, Knasmueller S, Knudsen LE, Kirsch-Volders M, Deo P, Franzke B, Stopper H, Andreassi MG, Bolognesi C, Dhillon VS, Laffon B, Wagner KH, Bonassi S. "Micronuclei and Disease" special issue: Aims, scope, and synthesis of outcomes. Mutat Res Rev Mutat Res 2021; 788:108384. [PMID: 34893149 DOI: 10.1016/j.mrrev.2021.108384] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 06/02/2021] [Indexed: 11/18/2022]
Abstract
The purpose of the "Micronuclei and Disease" special issue (SI) is to: (i) Determine the level of evidence for association of micronuclei (MN), a biomarker of numerical and structural chromosomal aberrations, with risk of specific diseases in humans; (ii) Define plausible mechanisms that explain association of MN with each disease; (iii) Identify knowledge gaps and research needed to translate MN assays into clinical practice. The "MN and Disease" SI includes 14 papers. The first is a review of mechanisms of MN formation and their consequences in humans. 11 papers are systematic reviews and/or meta-analyses of the association of MN with reproduction, child health, inflammation, auto-immune disease, glycation, metabolic diseases, chronic kidney disease, cardiovascular disease, eleven common cancers, ageing and frailty. The penultimate paper focuses on effect of interventions on MN frequency in the elderly. A road map for translation of MN data into clinical practice is the topic of the final paper. The majority of reviewed studies were case-control studies in which the ratio of mean MN frequency in disease cases relative to controls, i.e. the mean ratio (MR), was calculated. The mean of these MR values, estimated by meta-analyses, for lymphocyte and buccal cell MN in non-cancer diseases were 2.3 and 3.6 respectively, and for cancers they were 1.7 and 2.6 respectively. The highest MR values were observed in studies of cancer cases in which MN were measured in the same tissue as the tumour (MR = 4.9-10.8). This special issue is an important milestone in the evidence supporting MN as a reliable genomic biomarker of developmental and degenerative disease risk. These advances, together with results from prospective cohort studies, are helping to identify diseases in which MN assays can be practically employed in the clinical setting to better identify high risk patients and to prioritise them for preventive therapy.
Collapse
Affiliation(s)
- Michael Fenech
- Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, 5000, Australia; Genome Health Foundation, North Brighton, SA, 5048, Australia; Universiti Kebangsaan Malaysia, 43600, Bangi, Selangor, Malaysia.
| | - Siegfried Knasmueller
- Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria
| | | | - Micheline Kirsch-Volders
- Laboratory for Cell Genetics, Department Biology, Faculty of Sciences and Bio-Engineering Sciences, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium
| | - Permal Deo
- Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, 5000, Australia
| | - Bernhard Franzke
- University of Vienna, Research Platform Active Ageing, Department of Nutritional Sciences, Althanstraße 14, 1090, Vienna, Austria
| | - Helga Stopper
- Institute of Pharmacology and Toxicology, University of Wuerzburg, Wuerzburg, Germany
| | | | - Claudia Bolognesi
- Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino, Genoa, Italy
| | - Varinderpal S Dhillon
- Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, 5000, Australia
| | - Blanca Laffon
- Universidade da Coruña, Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Psicología, Facultad de Ciencias de la Educación, Campus Elviña s/n, 15071 A, Coruña, Spain; Instituto de Investigacio'n Biome'dica de A Coruña (INIBIC), AE CICA-INIBIC, Oza, 15071 A, Coruña, Spain
| | - Karl-Heinz Wagner
- University of Vienna, Research Platform Active Ageing, Department of Nutritional Sciences, Althanstraße 14, 1090, Vienna, Austria
| | - Stefano Bonassi
- Unit of Clinical and Molecular Epidemiology, IRCSS San Raffaele Pisana, Rome, Italy; Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Via di Val Cannuta, 247, 00166, Rome, Italy
| |
Collapse
|
16
|
Galea KS, Porras SP, Viegas S, Bocca B, Bousoumah R, Duca RC, Godderis L, Iavicoli I, Janasik B, Jones K, Knudsen LE, Leese E, Leso V, Louro H, Ndaw S, Ruggieri F, Sepai O, Scheepers PTJ, Silva MJ, Wasowicz W, Santonen T. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium. Int J Hyg Environ Health 2021; 234:113725. [PMID: 33714856 DOI: 10.1016/j.ijheh.2021.113725] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2020] [Revised: 02/22/2021] [Accepted: 02/25/2021] [Indexed: 01/21/2023]
Abstract
The EU human biomonitoring initiative, HBM4EU, aims to co-ordinate and advance human biomonitoring (HBM) across Europe. As part of HBM4EU, we presented a protocol for a multicentre study to characterize occupational exposure to hexavalent chromium (Cr(VI)) in nine European countries (HBM4EU chromates study). This study intended to collect data on current occupational exposure and to test new indicators for chromium (Cr) biomonitoring (Cr(VI) in exhaled breath condensate and Cr in red blood cells), in addition to traditional urinary total Cr analyses. Also, data from occupational hygiene samples and biomarkers of early biological effects, including genetic and epigenetic effects, was obtained, complementing the biomonitoring information. Data collection and analysis was completed, with the project findings being made separately available. As HBM4EU prepares to embark on further European wide biomonitoring studies, we considered it important to reflect on the experiences gained through our harmonised approach. Several practical aspects are highlighted for improvement in future studies, e.g., more thorough/earlier training on the implementation of standard operating procedures for field researchers, training on the use of the data entry template, as well as improved company communications. The HBM4EU chromates study team considered that the study had successfully demonstrated the feasibility of conducting a harmonised multicentre investigation able to achieve the research aims and objectives. This was largely attributable to the engaged multidisciplinary network, committed to deliver clearly understood goals. Such networks take time and investment to develop, but are priceless in terms of their ability to deliver and facilitate knowledge sharing and collaboration.
Collapse
Affiliation(s)
- Karen S Galea
- Institute of Occupational Medicine (IOM), Research Avenue North, Riccarton, Edinburgh, EH14 4AP, United Kingdom.
| | - Simo P Porras
- Finnish Institute of Occupational Health, P.O. Box 40, FI-00032, Työterveyslaitos, Finland
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), 1169-056, Lisbon, Portugal; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1500-310, Lisboa, Portugal
| | | | - Radia Bousoumah
- French National Research and Safety Institute (INRS), France
| | - Radu Corneliu Duca
- National Health Laboratory (LNS), Department of Health Protection, Unit Environmental Hygiene and Human Biological Monitoring, 1 Rue Louis Rech, 3555, Dudelange, Luxembourg; KU Leuven, Centre for Environment and Health, Leuven, Belgium
| | - Lode Godderis
- KU Leuven, Centre for Environment and Health, Leuven, Belgium; IDEWE, External Service for Prevention and Protection at Work, 3001, Heverlee, Belgium
| | - Ivo Iavicoli
- Department of Public Health, University of Naples Federico II, Italy
| | | | - Kate Jones
- Health & Safety Executive, Buxton, SK17 9JN, United Kingdom
| | | | | | - Veruscka Leso
- Department of Public Health, University of Naples Federico II, Italy
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade Nova de Lisboa, Portugal
| | - Sophie Ndaw
- French National Research and Safety Institute (INRS), France
| | | | | | - Paul T J Scheepers
- Radboud Institute for Health Sciences, Radboudumc, Nijmegen, the Netherlands
| | - Maria J Silva
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade Nova de Lisboa, Portugal
| | | | - Tiina Santonen
- Finnish Institute of Occupational Health, P.O. Box 40, FI-00032, Työterveyslaitos, Finland
| |
Collapse
|
17
|
Mathiesen L, Buerki-Thurnherr T, Pastuschek J, Aengenheister L, Knudsen LE. Fetal exposure to environmental chemicals; insights from placental perfusion studies. Placenta 2021; 106:58-66. [DOI: 10.1016/j.placenta.2021.01.025] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Revised: 10/19/2020] [Accepted: 01/22/2021] [Indexed: 12/27/2022]
|
18
|
Harnung Scholten R, Møller P, Jovanovic Andersen Z, Dehlendorff C, Khan J, Brandt J, Ketzel M, Knudsen LE, Mathiesen L. Telomere length in newborns is associated with exposure to low levels of air pollution during pregnancy. Environ Int 2021; 146:106202. [PMID: 33120230 DOI: 10.1016/j.envint.2020.106202] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2020] [Revised: 10/06/2020] [Accepted: 10/08/2020] [Indexed: 06/11/2023]
Abstract
Telomere length (TL) is a biomarker of biological aging that may be affected by prenatal exposure to air pollution. The aim of this study was to assess the association between prenatal exposure to air pollution and TL in maternal blood cells (leukocytes), placenta and umbilical cord blood cells, sampled immediately after birth in 296 Danish mother-child pairs from a birth cohort. Exposure data was obtained using the high-resolution and spatial-temporal air pollution modeling system DEHM-UBM-AirGIS for PM2.5, PM10, SO2, NH4+, black carbon (BC), organic carbon (OC), CO, O3, NO2, and NOx at residential and occupational addresses of the participating women for the full duration of the pregnancy. The association between prenatal exposure to air pollutants and TL was investigated using distributed lag models. There were significant and positive associations between TL in umbilical cord blood cells and prenatal exposure to BC, OC, NO2, NOx, CO, and O3 during the second trimester. TL in umbilical cord blood was significantly and inversely associated with prenatal exposure to PM2.5, BC, OC, SO2, NH4+, CO and NO2 during the third trimester. There were similar inverse associations between TL from umbilical cord blood cells and air pollution exposure at the residential and occupational addresses. There were weaker or no associations between air pollution exposure and TL in placenta tissue and maternal blood cells. In conclusion, both the second and third trimesters of pregnancy are shown to be sensitive windows of exposure to air pollution affecting fetal TL.
Collapse
Affiliation(s)
- Rebecca Harnung Scholten
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark
| | - Peter Møller
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark
| | - Zorana Jovanovic Andersen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark; Nykøbing Falster Hospital, Center for Epidemiological Research, Ejegodvej 63, DK-4800 Nykøbing, Denmark
| | - Christian Dehlendorff
- Statistics and Data Analysis, Danish Cancer Society Research Center, Copenhagen, Denmark
| | - Jibran Khan
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, POB 358, DK-4000 Roskilde, Denmark; Danish Big Data Centre for Environment and Health (BERTHA) at University of Aarhus, DK-4000 Roskilde, Denmark
| | - Jørgen Brandt
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, POB 358, DK-4000 Roskilde, Denmark
| | - Matthias Ketzel
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, POB 358, DK-4000 Roskilde, Denmark; Global Centre for Clean Air Research (GCARE), University of Surrey, Guildford GU2 7XH, United Kingdom
| | - Lisbeth E Knudsen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark
| | - Line Mathiesen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark.
| |
Collapse
|
19
|
Knudsen LE, Kirsch-Volders M. Micronuclei, reproduction and child health. Mutat Res Rev Mutat Res 2020; 787:108345. [PMID: 34083036 DOI: 10.1016/j.mrrev.2020.108345] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Revised: 10/30/2020] [Accepted: 11/04/2020] [Indexed: 11/26/2022]
Abstract
The current review looks for relationships between results from biomarker studies with micronucleus and health effects related to reproduction and children. In adults, an age related increase in MN is well known as well as associations with environmental exposures especially air pollution from traffic and smoking. Literature searches in PubMED and SCOPUS were performed with the following keywords reproduction, children, micronuclei, health effects. In total 162 studies were identified with the keyword children. Concerning children and health and children and environmental exposures, the titles and abstracts of a total of 162 publications were screened for language, inclusion of data from children and selected according to a study selection chart. 9 studies were included for children and health, and 21 studies for children and environmental exposures, with 12 in buccal cells and 9 in lymphocytes. The publications were read and included in tables if data on controls was available. MN frequencies were collected for peripheral blood lymphocytes (PBLs), reticulocytes or buccal cells (BC) and reported as Mean ± SD or Median (IQR). The Mean frequency Ratio, MRi, corresponding to the MN mean for study persons divided by MN mean for control persons was stated as reported in the publication or calculated by us from the data in the publication, where possible. Our systematic analysis revealed a number of positive associations of MN frequencies as a marker of increased health risk in relation to reproduction as well as child health. The majority of studies reported with children concerns exposures of children as well as maternal exposures and newborn health with MN as a biomarker of exposure. Exposure monitoring by MN as biomarker is also reported in studies of school children however most often not related to health effects. The MRis are found in ranges from 1 to 5.5 most studies around 2. As far as MN frequencies in children and exposure are concerned, the MRis range from 0.9 to 5.5, with a range from 1.3-4.9 for lymphocytes and from 1.5 to 2.5 in buccal cells, except for two studies with no differences found between cases and controls. Only one study is available for MRi calculation in reticulocytes with the value of 2.3. These data are supporting MN as a relevant biomarker for children health. However, the data is mostly from small studies with different protocol leaving out the possibility of metanalyses and even statistical comparisons among studies. The actual risk from elevated MNs in children waits large cohort studies with pooled datasets as performed with MN measured in adults. Introduction of buccal cells as non invasive alternative to lymphocytes is increasing and as with the lymphocytes standardised protocols are recommended to enable comparative studies and metaanalyses.
Collapse
Affiliation(s)
| | - Micheline Kirsch-Volders
- Laboratory for Cell Genetics, Department Biology, Faculty of Sciences and Bio-engineering Sciences, Vrije Universiteit Brussel, Belgium
| |
Collapse
|
20
|
Zeka A, Tobias A, Leonardi G, Bianchi F, Lauriola P, Crabbe H, Vardoulakis S, Guo Y, Honda Y, Gasparrini A, Hashizume M, Vicedo AM, Knudsen LE, Sera F, Ashworth M. Responding to COVID-19 requires strong epidemiological evidence of environmental and societal determining factors. Lancet Planet Health 2020; 4:e375-e376. [PMID: 32918880 PMCID: PMC7480994 DOI: 10.1016/s2542-5196(20)30169-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Accepted: 07/01/2020] [Indexed: 06/11/2023]
Affiliation(s)
- Ariana Zeka
- Institute of Environment, Health and Societies, Brunel University London, London UB8 3PH, UK.
| | - Aurelio Tobias
- Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research, Barcelona, Spain
| | - Giovanni Leonardi
- Centre for Radiation, Chemicals and Environment Hazards, Public Health England, Didcot, UK; Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK
| | - Fabrizio Bianchi
- Institute of Clinical Physiology, National Research Council, Pisa, Italy
| | - Paolo Lauriola
- Institute of Clinical Physiology, National Research Council, Pisa, Italy
| | - Helen Crabbe
- Centre for Radiation, Chemicals and Environment Hazards, Public Health England, Didcot, UK
| | - Sotiris Vardoulakis
- National Centre for Epidemiology and Population Health, Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, Australia
| | - Yuming Guo
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - Yasushi Honda
- Center for Climate Change Adaptation, National Institute for Environmental Studies, Tsukuba, Japan
| | - Antonio Gasparrini
- Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK
| | - Masahiro Hashizume
- Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Ana Maria Vicedo
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
| | - Lisbeth E Knudsen
- Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Francesco Sera
- Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK
| | - Matthew Ashworth
- Institute of Environmental Science and Research, Christchurch Science Centre, Christchurch, New Zealand
| |
Collapse
|
21
|
Andersen HV, Gunnarsen L, Knudsen LE, Frederiksen M. PCB in air, dust and surface wipes in 73 Danish homes. Int J Hyg Environ Health 2020; 229:113429. [DOI: 10.1016/j.ijheh.2019.113429] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 11/22/2019] [Accepted: 12/03/2019] [Indexed: 11/30/2022]
|
22
|
Mathiesen L, Mørck TA, Poulsen MS, Nielsen JKS, Mose T, Long M, Bonefeld-Jørgensen E, Bossi R, Knudsen LE. Placental transfer of pesticides studied in human placental perfusion. Basic Clin Pharmacol Toxicol 2020; 127:505-515. [PMID: 32558230 PMCID: PMC7689789 DOI: 10.1111/bcpt.13456] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 06/10/2020] [Accepted: 06/10/2020] [Indexed: 12/18/2022]
Abstract
To investigate the transplacental transport of pesticides, the pyrethroid cypermethrin and the fungicide azoles, propiconazole and bitertanol were tested in the placental perfusion model. Cypermethrin, propiconazole and bitertanol were also tested in the BeWo cell transfer model. The pesticides were chosen with the selection criteria: use in Denmark, significant treated areas and knowledge on hormone-disrupting effects. Propiconazole and bitertanol showed rapid transfer and adsorbance to the system in both placental perfusion and BeWo cell system, whereas cypermethrin had a slower transport across the placental cell layers in the two models. There was no difference between data of the single pesticides and their mixture in either placental perfusion or BeWo cell transfer model. Both the placental perfusion model and the BeWo cell model metabolized the pesticides and released metabolites into both foetal and maternal circulation. Using human exposure models, this study shows the potential exposure of the human foetus to pesticides cypermethrin, propiconazole and bitertanol and their metabolites.
Collapse
Affiliation(s)
- Line Mathiesen
- Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
| | - Thit Aarøe Mørck
- Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
| | - Marie Sønnegaard Poulsen
- Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
| | | | - Tina Mose
- Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
| | - Manhai Long
- Department of Public Health, Centre for Arctic Heath and Molecular Epidemiology, Aarhus University, Aarhus C, Denmark
| | - Eva Bonefeld-Jørgensen
- Department of Public Health, Centre for Arctic Heath and Molecular Epidemiology, Aarhus University, Aarhus C, Denmark
| | - Rossana Bossi
- Department of Public Health, Centre for Arctic Heath and Molecular Epidemiology, Aarhus University, Aarhus C, Denmark.,Department of Environmental Science, Aarhus University, Roskilde, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
| |
Collapse
|
23
|
Mathiesen L, Bay-Richter C, Wegener G, Liebenberg N, Knudsen LE. Maternal stress and placental function; ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin. PLoS One 2020; 15:e0233979. [PMID: 32492052 PMCID: PMC7269612 DOI: 10.1371/journal.pone.0233979] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Accepted: 05/16/2020] [Indexed: 11/27/2022] Open
Abstract
Background Exposure to maternal stress during pregnancy can have adverse effects on the fetus, which has potential long-term effects on offspring´s development and health. We investigated the kinetics and metabolism of the hormones and amino acids: cortisol, cortisone, tryptophan and serotonin in the term placenta in an ex vivo human placental perfusion model. The placentas used in the experiments were donated from families participating in the Maternal Stress and Placental Function project with a known maternal stress background. Method Cortisol, cortisone, tryptophan and serotonin were added simultaneously to the maternal side in the 6 hour ex vivo term human recirculating placental perfusion model, in four experimental set-ups: without inhibitors, with carbenoxolone -that inhibits cortisol metabolism into cortisone, with fluoxetine that inhibits the serotonin transporter, and with PCPA that inhibits metabolism of tryptophan into serotonin. The concentration of cortisol and cortisone, and tryptophan and serotonin were quantified using UPLC and HPLC-MS respectively. Results Cortisol was rapidly metabolized into cortisone in the placenta, to a somewhat lesser degree when adding the inhibitor carbenoxolone, resulting in higher fetal exposure to cortisol. Serotonin was also rapidly metabolized in the placenta. When adding fluoxetine a peak of fetal serotonin levels was seen in the first hour of the perfusion. No effect was seen of the maternal stress levels on placental transport kinetics in this study. Conclusion Inhibiting the metabolism of cortisol in the placenta increased fetal exposure to cortisol as expected. Unexpectedly we saw an increased fetal exposure to serotonin when inhibiting the serotonin transporter, which may be related to the increased serotonin concentration on the maternal side of the placenta. No effect on placental kinetics were evident on maternal stress levels during the pregnancy as the majority of participating mothers had normal stress levels.
Collapse
Affiliation(s)
- Line Mathiesen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark
- * E-mail:
| | - Cecilie Bay-Richter
- Department of Clinical Medicine, Translational Neuropsychiatry Unit, University of Aarhus, Aarhus, Denmark
| | - Gregers Wegener
- Department of Clinical Medicine, Translational Neuropsychiatry Unit, University of Aarhus, Aarhus, Denmark
| | - Nico Liebenberg
- Department of Clinical Medicine, Translational Neuropsychiatry Unit, University of Aarhus, Aarhus, Denmark
| | - Lisbeth E. Knudsen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
24
|
Knudsen LE, Phillips DH, Kirsch-Volders M. 50 years existence and active participation of EEMS (now EEMGS) in the scientific community: A driver of European and international scientific collaborations for the protection of the environment and human health from genome stressors. Mutat Res Genet Toxicol Environ Mutagen 2020; 850-851:503132. [PMID: 32247550 DOI: 10.1016/j.mrgentox.2020.503132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 12/06/2019] [Accepted: 01/07/2020] [Indexed: 10/25/2022]
Abstract
EEMS and its successor Society EEMGS have provided a dynamic and successful platform to stimulate research and exchanges among the different actors involved in the protection of the environment and of human health from exposure to genome stressors. It includes basic, translational and applied research projects. This was possible due to the enthusiasm, creativity and support of scientists convinced of the importance of these issues. In the future young scientists will take over with new questions, new challenges, new technologies, new discoveries and new applications. A major challenge is the ethical questions emerging from the impressive potential of present genetic technologies capable of impacting the evolution of nature and humankind. The EEMGS, where academics, regulators and industries meet, should play a central role in these aspects, in particular in support of primary prevention and the establishment of internationally recognized guidelines. Collaboration with colleagues and other teams are of great importance to establish a stimulating open dialogue on scientific questions. However the key issues remain to do careful and rigorous research; to use logic and background knowledge; to define adequate experimental designs; to provide transparency in the protocols; to check repeatability of the results and to combine several statistical approaches in the quest to get to the truth. Among the many challenges ahead, re-evaluation of some key fundamental questions is necessary, such as the interplay between genetics and epigenetics, the existence of specific germ cell mutagens or the identification of the mechanisms leading to mutagen induced diseases. Translational and applied research will further include the development of systemic biomonitoring protocols, if possible in a single biological sample, the redaction of internationally harmonized guidelines but also the organization of platforms between geneticists and physicians open to all actors in the field. The creation of an independent European center to assess risk from exposure to mutagens, in particular in the light of the problematic of global warming might be very helpful.
Collapse
Affiliation(s)
| | - David H Phillips
- Department of Analytical, Environmental & Forensic Sciences, MRC-PHE Centre for Environment & Health, King's College London, UK
| | - Micheline Kirsch-Volders
- Laboratory for Cell Genetics, Department Biology, Faculty of Sciences and Bio-engineering Sciences, Vrije Universiteit Brussel, Belgium
| |
Collapse
|
25
|
Stopper H, Knudsen LE, Le Hegarat L. Preface to the Special Issue dedicated to the 47th annual conference of the European Environmental Mutagen and Genomics Society (EEMGS). Mutat Res 2020; 850-851:503166. [PMID: 32247556 DOI: 10.1016/j.mrgentox.2020.503166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Helga Stopper
- Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher, Str. 9, 97078, Würzburg, Germany.
| | - Lisbeth E Knudsen
- Institute of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 1014, Copenhagen K, Denmark.
| | - Ludovic Le Hegarat
- ANSES, French Agency for Food, Environmental and Occupational Health and Safety, Fougères Laboratory, Toxicology of Contaminants Unit, 10 B rue Claude Bourgelat, Fougères, 35306, France.
| |
Collapse
|
26
|
Frederiksen M, Andersen HV, Haug LS, Thomsen C, Broadwell SL, Egsmose EL, Kolarik B, Gunnarsen L, Knudsen LE. PCB in serum and hand wipes from exposed residents living in contaminated high-rise apartment buildings and a reference group. Int J Hyg Environ Health 2020; 224:113430. [DOI: 10.1016/j.ijheh.2019.113430] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 11/06/2019] [Accepted: 12/03/2019] [Indexed: 02/02/2023]
|
27
|
Koppen G, Govarts E, Vanermen G, Voorspoels S, Govindan M, Dewolf MC, Den Hond E, Biot P, Casteleyn L, Kolossa-Gehring M, Schwedler G, Angerer J, Koch HM, Schindler BK, Castaño A, López ME, Sepai O, Exley K, Bloemen L, Knudsen LE, Joas R, Joas A, Schoeters G, Covaci A. Mothers and children are related, even in exposure to chemicals present in common consumer products. Environ Res 2019; 175:297-307. [PMID: 31146101 DOI: 10.1016/j.envres.2019.05.023] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 05/14/2019] [Accepted: 05/15/2019] [Indexed: 05/23/2023]
Abstract
BACKGROUND Phthalates, bisphenol A (BPA) and triclosan (TCS) are detectable in the vast majority of people. Most humans are continuously exposed to these chemicals due to their presence in food or in everyday consumer products. The measurement of these compounds in family members may help to explore the impact of major lifestyle factors on exposure. Mothers and (young) children are especially interesting to study, as they mostly share considerable parts of daily life together. MATERIALS AND METHODS Phthalate metabolites, bisphenol A (BPA) and triclosan (TCS) were measured in first morning void urine, collected in mother-child pairs (n = 129) on the same day. The mothers (27-45y) and their children (6-11y) were recruited in the Brussels agglomeration and rural areas of Belgium in the context of the European COPHES-DEMOCOPHES human biomonitoring project. Face-to-face questionnaires gathered information on major exposure sources and lifestyle factors. Exposure determinants were assessed by multiple linear regression analysis. RESULTS The investigated compounds were detectable in nearly all mothers (92.8-100%) and all children (95.2-100%). The range (P90 vs. P10) of differences in urinary concentrations within each age group was for most compounds around 10-20 fold, and was very high for TCS up to 35 and 350-fold in children and mothers respectively. Some participants exceeded the tolerable daily intake guidelines as far as they were available from the European Food Safety Authority (EFSA). Overall, for BPA, the urinary concentrations were similar among both age groups. Most urinary phthalate metabolites were higher in children compared to the mothers, except for monoethyl phthalate (MEP). TCS levels were generally higher in the mothers. Despite the difference in mothers' and children's urinary concentrations, the creatinine-corrected levels were correlated for all biomarkers (Spearman rank r = 0.32 to 0.66, p < 0.001). Furthermore, for phthalates, similar home and lifestyle factors were associated with the urinary concentrations in both age groups: home renovation during last two years or redecoration during the last year for di-ethyl phthalate (DEP); PVC in home for di-n-butyl phthalate (DnBP), di-iso-butyl phthalate (DiBP) and butyl benzyl phthalate (BBzP), and personal care products use for DiBP and DnBP. Based on questionnaire information on general food type consumption patterns, the exposure variability could not be explained. However, comparing the phthalate intake from the current study with earlier assessed Belgian food intake calculations for both ages, food in general was estimated to be the major intake source for di-ethyl hexyl phthalate (DEHP), with diminishing importance for BBzP, DiBP and DnBP. CONCLUSION Our results confirm, that children and their mothers, sharing diets and home environments, also share exposure in common consumer products related chemicals. By collecting morning urine levels on the same day, and using basic questionnaires, suspected exposure routes could be unraveled.
Collapse
Affiliation(s)
- Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
| | - Guido Vanermen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
| | - Stefan Voorspoels
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.
| | | | - Marie-Christine Dewolf
- Environment and Health Risk Assessment Hainaut Vigilance Sanitaire - Hygiène Publique en Hainaut, Mons, Belgium.
| | - Elly Den Hond
- Provincial Institute of Hygiene (PIH), Antwerp, Belgium
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, Brussels, Belgium.
| | - Ludwine Casteleyn
- University of Leuven, Center for Human Genetics, Herestraat 49, 3000 Leuven, Belgium.
| | | | - Gerda Schwedler
- German Environment Agency, Corrensplatz 1, 14195, Berlin, Germany.
| | - Jürgen Angerer
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
| | - Birgit K Schindler
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.
| | - Argelia Castaño
- Instituto de Salud Carlos III (ISCIII), National Centre for Environmental Health (CNSA) Ctra. Majadahonda - Pozuelo, Km. 2, 28220, Madrid, Spain.
| | - Marta Esteban López
- Instituto de Salud Carlos III (ISCIII), National Centre for Environmental Health (CNSA) Ctra. Majadahonda - Pozuelo, Km. 2, 28220, Madrid, Spain.
| | - Ovnair Sepai
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, Oxfordshire, OX11 0RQ, United Kingdom.
| | - Karen Exley
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, Oxfordshire, OX11 0RQ, United Kingdom.
| | - Louis Bloemen
- Environmental Health Science International, Lyceumstraat 2 4561 HV Hulst, the Netherlands.
| | - Lisbeth E Knudsen
- University of Copenhagen, Department of Public Health, Øster Farimagsgade 5, 1353 København, Denmark.
| | - Reinhard Joas
- Senior Advisor Environment and Health/chemicals, Grauertstrasse 12, 81545 Munich, Germany.
| | - Anke Joas
- Senior Advisor Environment and Health/chemicals, Grauertstrasse 12, 81545 Munich, Germany.
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Belgium; University of Southern Denmark, Institute of Public Health/ Department of Environmental Medicine, Odense, Denmark.
| | - Adrian Covaci
- Toxicological Center, University of Antwerp, Belgium.
| |
Collapse
|
28
|
Knudsen LE. Animal-free Toxicology: The Use of Human Tissue to Replace the Use of Animals — Examples from Human Biomonitoring and Human Placental Transport Studies. Altern Lab Anim 2019; 41:443-7. [DOI: 10.1177/026119291304100606] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Lisbeth E. Knudsen
- Section of Environmental Health, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
| |
Collapse
|
29
|
Joas A, Schöpel M, David M, Casas M, Koppen G, Esteban M, Knudsen LE, Vrijheid M, Schoeters G, Calvo AC, Schwedler G, Kolossa-Gehring M, Joas R. Environmental health surveillance in a future European health information system. Arch Public Health 2018; 76:27. [PMID: 29988356 PMCID: PMC6022511 DOI: 10.1186/s13690-018-0272-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 05/16/2018] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND To date Health information (HI) in the European Union does not comprise indicators or other information related to impacts of hazardous chemicals in consumer products, food, drinking water or air on the health status of the population. Therefore, we inventorised and evaluated the potential of environmental health surveillance and research data sources in the European population to provide HBM-based indicators of internal human exposure and health impact of relevant chemicals. METHODS We established an up-dated inventory of European cross-sectional Human Biomonitoring (HBM) surveys and of birth cohorts, and compared chemicals and chemical groups addressed by HBM with indicators and health end points collected via European Core Health Indicators (ECHI), in birth registries, as well as in environmental and food data bases and health registries to see on how data collection could be aligned. Finally, we investigated study designs of HBM survey and health examination surveys for potential synergies. RESULTS The inventory covers a total of 11 European cross-sectional national programmes and a large number of birth cohorts and includes information on study population, age groups, covered substances, sampled matrices, and frequency. The comparison of data collections shows that there are many overlaps between environmental chemicals with environmental and health reporting. HBM data could be linked with ECHI indicators for work-related risks, body mass index (BMI), and low birth weight, with perinatal disease, neurologic disorders, and some chronic diseases, or with data bases for e.g. indoor air, food, or consumer products. Existing initiatives to link data collections at European Environment Agency (EEA) and Joint Research Center (JRC) or at World Health Organization (WHO) are good options to further develop linkage of HBM with exposures sources and health end points. CONCLUSIONS There is potential to use HBM based information in a number of public health policies, and this would help to align reporting to international commitments. Environmental health surveillance based on HBM and HBM-based indicators, is an excellent tool to inform public health policies about risks from environmental chemicals, and the EU health information system would benefit from additional HBM-based indicators for monitoring exposure burden from environmental chemicals. Considerable efforts are needed to align and establish routine data collections and to develop a surveillance system and indicators which may inform public health policies.
Collapse
Affiliation(s)
- Anke Joas
- BiPRO GmbH, Werinherstr. 79, 81541 Munich, Germany
| | | | | | - Maribel Casas
- ISGlobal, Barcelona, Spain
- Universitat Pompeu Fabra (UPF), Barcelona, Spain
- Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Valencia, Spain
| | - Gudrun Koppen
- Flemish Institute for Technological Research, Mol, Belgium
| | - Marta Esteban
- CNSA - ISCIII, National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Martine Vrijheid
- ISGlobal, Barcelona, Spain
- Universitat Pompeu Fabra (UPF), Barcelona, Spain
- Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Valencia, Spain
| | | | - Argelia Castaño Calvo
- CNSA - ISCIII, National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | | | | |
Collapse
|
30
|
Frederiksen M, Stapleton HM, Vorkamp K, Webster TF, Jensen NM, Sørensen JA, Nielsen F, Knudsen LE, Sørensen LS, Clausen PA, Nielsen JB. Dermal uptake and percutaneous penetration of organophosphate esters in a human skin ex vivo model. Chemosphere 2018; 197:185-192. [PMID: 29353672 DOI: 10.1016/j.chemosphere.2018.01.032] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Revised: 01/04/2018] [Accepted: 01/09/2018] [Indexed: 05/22/2023]
Abstract
Organophosphate esters (OPEs) are used as flame retardants, plasticizers, and as hydraulic fluids. They are present in indoor environments in high concentrations compared with other flame retardants, and human exposure is ubiquitous. In this study we provide data for estimating dermal uptake for eight OPEs and ranking in OPEs risk assessment. Dermal uptake and percutaneous penetration of the OPEs were studied in a Franz diffusion cell system using human skin dosed with a mixture of OPEs in an ethanol:toluene (4:1) solution. Large variation in penetration profiles was observed between the OPEs. The chlorinated OPEs tris(2-chloroisopropyl) phosphate (TCIPP), and in particular tris(2-chloroethyl) phosphate (TCEP), penetrated the skin quite rapidly while tris(1,3-dichlor-2-propyl) phosphate (TDCIPP) and triphenyl phosphate (TPHP) tended to build up in the skin tissue and only smaller amounts permeated through the skin. For tris(isobutyl) phosphate (TIBP), tris(n-butyl) phosphate (TNBP), and tris(methylphenyl) phosphate (TMPP) the mass balance was not stable over time indicating possible degradation during the experimental period of 72 h. The rates at which OPEs permeated through the skin decreased in the order TCEP > TCIPP ≥ TBOEP > TIBP ≥ TNBP > TDCIPP > TPHP > TMPP. Generally, the permeation coefficient, kp, decreased with increasing log Kow, whereas lag time and skin deposition increased with log Kow. The present data indicate that dermal uptake is a non-negligible human exposure pathway for the majority of the studied OPEs.
Collapse
Affiliation(s)
- Marie Frederiksen
- Danish Building Research Institute, Aalborg University, A.C. Meyers Vænge 15, 2400, Copenhagen SV, Denmark; National Research Centre for the Working Environment, Lersø Parkallé 105, 2100, Copenhagen Ø, Denmark.
| | - Heather M Stapleton
- Nicholas School of the Environment, Duke University, LSRC Box 90328, Durham, NC 27708, USA
| | - Katrin Vorkamp
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, 4000, Roskilde, Denmark
| | - Thomas F Webster
- Department of Environmental Health, Boston University School of Public Health, 715 Albany St, Boston, MA 02118, USA
| | - Niels Martin Jensen
- Department of Plastic and Reconstructive Surgery, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark
| | - Jens Ahm Sørensen
- Department of Plastic and Reconstructive Surgery, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark
| | - Flemming Nielsen
- Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 9B, 5000, Odense C, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 2100, Copenhagen Ø, Denmark
| | - Lars S Sørensen
- Danish Building Research Institute, Aalborg University, A.C. Meyers Vænge 15, 2400, Copenhagen SV, Denmark
| | - Per Axel Clausen
- National Research Centre for the Working Environment, Lersø Parkallé 105, 2100, Copenhagen Ø, Denmark
| | - Jesper B Nielsen
- Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 9B, 5000, Odense C, Denmark
| |
Collapse
|
31
|
Cullen E, Evans D, Griffin C, Burke P, Mannion R, Burns D, Flanagan A, Kellegher A, Schoeters G, Govarts E, Biot P, Casteleyn L, Castaño A, Kolossa-Gehring M, Esteban M, Schwedler G, Koch HM, Angerer J, Knudsen LE, Joas R, Joas A, Dumez B, Sepai O, Exley K, Aerts D. Urinary Phthalate Concentrations in Mothers and Their Children in Ireland: Results of the DEMOCOPHES Human Biomonitoring Study. Int J Environ Res Public Health 2017; 14:ijerph14121456. [PMID: 29186834 PMCID: PMC5750875 DOI: 10.3390/ijerph14121456] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/20/2017] [Revised: 11/17/2017] [Accepted: 11/22/2017] [Indexed: 11/29/2022]
Abstract
Background: Phthalates are chemicals which are widespread in the environment. Although the impacts on health of such exposure are unclear, there is evidence of a possible impact on the incidence of a diverse range of diseases. Monitoring of human exposure to phthalates is therefore important. This study aimed to determine the extent of phthalate exposure among mothers and their children in both rural and urban areas in Ireland, and to identify factors associated with elevated concentrations. It formed part of the ‘Demonstration of a study to Co-ordinate and Perform Human Biomonitoring on a European Scale’ (DEMOCOPHES) pilot biomonitoring study. Methods: the concentration of phthalate metabolites were determined from a convenience sample of 120 mother/child pairs. The median age of the children was 8 years. A questionnaire was used to collect information regarding lifestyle and environmental conditions of the children and mothers. Rigorous quality assurance within DEMOCOPHES guaranteed the accuracy and international comparability of results. Results: Phthalate metabolites were detected in all of the samples from both children and mothers. Concentrations were significantly higher in respondents from families with lower educational attainment and in those exposed to such items as polyvinyl chloride (PVC), fast food and personal care products (PCP). Conclusions: The study demonstrates that human biomonitoring for assessing exposure to phthalates can be undertaken in Ireland and that the exposure of the population is widespread. Further work will be necessary before the consequences of this exposure are understood.
Collapse
Affiliation(s)
- Elizabeth Cullen
- Department of Community of Health, Health Service Executive, St. Mary’s, Naas, Kildare W91 NR29, Ireland
- Correspondence: ; Tel.: +353-45-882-403
| | - David Evans
- Department of Public Health, Health Service Executive, Galway H91973, Ireland;
| | - Chris Griffin
- Public Analyst’s Laboratory, Health Service Executive, Dublin D02 P667, Ireland;
| | - Padraig Burke
- Public Analyst’s Laboratory, Health Service Executive, Galway H91 Y952, Ireland; (P.B.); (R.M.); (A.F.)
| | - Rory Mannion
- Public Analyst’s Laboratory, Health Service Executive, Galway H91 Y952, Ireland; (P.B.); (R.M.); (A.F.)
| | - Damien Burns
- Project Manager, Health Service Executive, Palmerstown, Dublin D20 X318, Ireland;
| | - Andrew Flanagan
- Public Analyst’s Laboratory, Health Service Executive, Galway H91 Y952, Ireland; (P.B.); (R.M.); (A.F.)
| | - Ann Kellegher
- Environmental Health Service, Health Service Executive, Carrick on Shannon, Co Leitrim N41 XC59, Ireland;
| | - Greet Schoeters
- Flemish Institute for Technological Research (VITO), Sustainable Health Mol B-2400, Belgium; (G.S.); (E.G.)
- Biomedical Department, University of Antwerp, B-2000 Antwerp, Belgium
| | - Eva Govarts
- Flemish Institute for Technological Research (VITO), Sustainable Health Mol B-2400, Belgium; (G.S.); (E.G.)
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, Brussels 1060, Belgium;
| | - Ludwine Casteleyn
- Center for Human Genetics, University of Leuven, Herestraat 49, 3000 Leuven, Belgium; (L.C.); (B.D.)
| | - Argelia Castaño
- Carlos 111 Institute of Health, National Centre for Environmental Health, Majadahonda, Madrid 28220, Spain; (A.C.); (M.E.)
| | | | - Marta Esteban
- Carlos 111 Institute of Health, National Centre for Environmental Health, Majadahonda, Madrid 28220, Spain; (A.C.); (M.E.)
| | - Gerda Schwedler
- German Environment Agency, Berlin 14195, Germany; (M.K.-G.); (G.S.)
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum 44789, Germany; (H.M.K.); (J.A.)
| | - Jürgen Angerer
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum 44789, Germany; (H.M.K.); (J.A.)
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen, Copenhagen 1353, Denmark;
| | | | - Anke Joas
- BiPRO GmbH, Munich 81545, Germany; (R.J.); (A.J.)
| | - Birgit Dumez
- Center for Human Genetics, University of Leuven, Herestraat 49, 3000 Leuven, Belgium; (L.C.); (B.D.)
| | - Ovnair Sepai
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton OX11 ORQ, Oxfordshire OX11 ORQ, UK; (O.S.); (K.E.)
| | - Karen Exley
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton OX11 ORQ, Oxfordshire OX11 ORQ, UK; (O.S.); (K.E.)
| | - Dominique Aerts
- Federal Public Service Health, Food Chain Safety and Environment, Brussels 1060, Belgium;
| |
Collapse
|
32
|
Knudsen LE, Hansen PW, Mizrak S, Hansen HK, Mørck TA, Nielsen F, Siersma V, Mathiesen L. Biomonitoring of Danish school children and mothers including biomarkers of PBDE and glyphosate. Rev Environ Health 2017; 32:279-290. [PMID: 28306542 DOI: 10.1515/reveh-2016-0067] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Accepted: 01/17/2017] [Indexed: 05/21/2023]
Abstract
BACKGROUND The Danish part of the large European Human biomonitoring pilot project Demonstration of a study to Coordinate and Perform Human biomonitoring on a European Scale (DEMOCOPHES) investigated the urine, hair and blood concentrations of 66 different environmental chemicals in a group of 145 Danish school children aged 6-11 years and their mothers from rural and urban areas in autumn 2011. Some - but not all - results were published; however, the concurrence of the chemicals has not been assessed. METHODS The measured concentrations of polybrominated diphenyl ethers (PBDEs) and glyphosate is assessed to complete the investigation of all 66 chemicals in DEMOCOPHES. The concentrations of PBDEs were measured in plasma samples of 143 mothers and 116 children. Glyphosate was measured in a subsample of 27 urine samples. Previously assessed chemicals were polychlorinated biphenyls (PCBs), and polyfluoroalkyl substances (PFASs) analyzed in blood samples, mercury analyzed in hair, and phthalate metabolites, parabens, phenols, cadmium, paracetamol and cotinine analyzed in urine samples. Differences in concentrations between mothers and children were assessed, and the associations between the concentrations of the different environmental chemicals. investigated by correlation analysis. RESULTS PBDE47 was found in relatively high levels compared with previous Danish results in both mothers and children, with a significantly higher level in the children compared to their mothers. Glyphosate in concentrations around 1 ng/mL was detected in all 27 samples. The analyzed environmental exposures seem to follow a pattern where chemicals within the same classes are strongly correlated and where children and mothers are exposed to the same chemicals. CONCLUSION The correlations between the measured environmental chemicals indicate that a specific exposure pattern may exist, where people who are highly exposed to one class of environmental chemicals also may be highly exposed to certain other classes. As some of the compounds were measured in higher levels in children compared to mothers, increased focus also on the exposure in young children is recommended. For more detailed investigation of specific exposure sources more studies with increased power and detailed questionnaires should be developed.
Collapse
|
33
|
Holme JA, Froetschl R, Knudsen LE. The European Environmental Mutagenesis and Genomics Society Annual Meeting, 14-18 August 2016, Copenhagen, Denmark. Basic Clin Pharmacol Toxicol 2017. [DOI: 10.1111/bcpt.12750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Jørn A. Holme
- Division of Environmental medicine; Norwegian Institute of Public Health; Oslo Norway
| | | | - Lisbeth E. Knudsen
- Department of Public Health; University of Copenhagen; Copenhagen Denmark
| |
Collapse
|
34
|
Mose T, Knudsen LE, Hedegaard M, Mortensen GK. Transplacental Transfer of Monomethyl Phthalate and Mono(2-ethylhexyl) Phthalate in a Human Placenta Perfusion System. Int J Toxicol 2017; 26:221-9. [PMID: 17564903 DOI: 10.1080/10915810701352721] [Citation(s) in RCA: 67] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The transplacental passage of monomethylphtalate (mMP) and mono (2-ethylhexyl) phthalate (mEHP) was studied using an ex vivo placental perfusion model with simultaneous perfusion of fetal and maternal circulation in a single cotyledon. Umbilical cord blood and placental tissue collected both before and after perfusion were also analyzed. Placentas were obtained immediately after elective cesarean section and dually perfused in a recirculation system. mMP or mEHP was added to maternal perfusion medium to obtain concentrations at 10 and 25 μg/L, respectively. The placental transfer was followed analyzing samples from fetal and maternal perfusion media by liquid chromatography–mass spectrometry–mass spectrometry (LC-MS-MS). Four perfusions with mMP indicated a slow transplacental transfer, with a fetomaternal ratio (FM ratio) of 0.30 ± 0.03 after 150 min of perfusion. Four perfusions with mEHP indicated a very slow or nonexisting placental transfer. mEHP was only detected in fetal perfusion media from two perfusions, giving rise to FM ratios of 0.088 and 0.20 after 150 min of perfusion. Detectable levels of mMP, mEHP, monoethylphthalate (mEP), and monobutylphthalate were found in tissue. Higher tissue levels of mMP after perfusions with mMP compared to perfusions with mEHP suggest an accumulation of mMP during perfusion. No tendency for accumulation of mEHP was observed during perfusions with mEHP compared to perfusions with mMP. Detectable levels of mEHP and mEP were found in umbilical cord plasma samples. mMP and possibly other short-chained phthalate monoesters in maternal blood can cross the placenta by slow transfer, whereas the results indicate no placental transfer of mEHP. Further studies are recommended.
Collapse
Affiliation(s)
- Tina Mose
- Department of Environmental and Occupational Health, Institute of Public Health, University of Copenhagen, Denmark.
| | | | | | | |
Collapse
|
35
|
Bengtsson J, Thygesen PS, Kaerlev L, Knudsen LE, Bonde JP. Potential exposure to endocrine disrupting chemicals and selected adverse pregnancy outcomes: a follow-up study of pregnant women referred for occupational counselling. J Occup Med Toxicol 2017; 12:6. [PMID: 28286539 PMCID: PMC5343296 DOI: 10.1186/s12995-017-0152-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Accepted: 03/03/2017] [Indexed: 01/31/2023] Open
Abstract
BACKGROUND Experimental evidence indicates that fetal exposure to xenobiotics with the potential to interfere with the endogenous steroid hormone regulation of fetal development may reduce birth weight. However, epidemiological studies are limited. The aim of the study was to investigate whether potential occupational exposure to endocrine disrupting chemicals (EDC) of the mother during pregnancy is associated with preterm birth and low birth weight. METHODS Pregnant women referred to an Occupational Health Clinic (OHC) in two Danish regions (Copenhagen or Aarhus) between 1984 and 2010, suspected of being exposed to occupational reproductive hazards were included in the study. A job exposure matrix enabled estimation of potential occupational exposure to EDC on the basis of job title. Births by women potentially exposed to EDC (n = 582) were compared to births by women referred to an OHC on the suspicion of other exposures than EDC (n = 620), and to a sample of births by all occupationally active women in the same geographical regions (n = 346,544), including 1,077 births of the referred women's non-referred pregnancies. RESULTS No indications of reduced birth weight or increased risk of preterm birth were found among women potentially exposed to EDC. Women potentially exposed to EDC had children with a higher birth weight compared to the sample of occupationally active women but not compared to other women referred to an OHC. CONCLUSIONS Potential maternal exposure to EDC at Danish workplaces is not related to low birth weight or preterm birth among women referred to occupational counselling. Occupational exposures might be too weak on the average to cause these adverse effects or counselling at the OHCs is effective in preventing them.
Collapse
Affiliation(s)
- Jessica Bengtsson
- Department of Occupational and Environmental Medicine, Frederiksberg and Bispebjerg Hospitals, Bispebjerg Bakke 23, Copenhagen, NV DK-2400 Denmark
| | - Pernille Søgaard Thygesen
- Department of Occupational and Environmental Medicine, Frederiksberg and Bispebjerg Hospitals, Bispebjerg Bakke 23, Copenhagen, NV DK-2400 Denmark
| | - Linda Kaerlev
- Research Unit of Clinical Epidemiology, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.,Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark
| | - Jens Peter Bonde
- Department of Occupational and Environmental Medicine, Frederiksberg and Bispebjerg Hospitals, Bispebjerg Bakke 23, Copenhagen, NV DK-2400 Denmark.,Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
36
|
Knudsen LE, Andersen ZJ, Sram RJ, Braun Kohlová M, Gurzau ES, Fucic A, Gribaldo L, Rossner P, Rossnerova A, Máca V, Zvěřinová I, Gajdosova D, Moshammer H, Rudnai P, Ščasný M. Perinatal health in the Danube region - new birth cohort justified. Rev Environ Health 2017; 32:9-14. [PMID: 27754971 DOI: 10.1515/reveh-2016-0038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Accepted: 09/11/2016] [Indexed: 06/06/2023]
Abstract
In 2013-2015, a consortium of European scientists - NEWDANUBE - was established to prepare a birth cohort in the Danube region, including most of the countries with the highest air pollution in Europe, the area being one-fifth of the European Union's (EU's) territory, including 14 countries (nine EU member states), over 100 million inhabitants, with numerous challenges: big socioeconomic disparities, and a region-specific environmental pollution. The consortium reflects the EU Strategy for the Danube Region Strategy (2010), which identified 11 thematic Priority Areas - one of which is the environmental risks. Birth cohorts have been established in all other areas of Europe and collaborative efforts in promoting maternal and fetal health by minimizing the environmental exposures have been initiated with national, European, and international financial support. A birth cohort in the Danube area could apply the established methodologies for prenatal exposure and birth outcome measurements and establish a platform for targeted health promotion in couples planning pregnancies. The consortium included a strong socioeconomic part focusing on the participant's active registration of exposures to environmental toxicants and health indicators of disease and wellbeing, combined with investigation of their risk-reducing behavior and interventions to change their lifestyle to avoid the adverse health risks. Willingness to pay for reducing the health risks in children is also proposed to be estimated. Further collaboration and networking is encouraged as the Danube region has several decades of experience and expertise in biomonitoring adult populations exposed environmentally or occupationally. Additionally, some countries in the Danube region launched small-scale birth cohorts encouraged by participation in several ongoing research projects.
Collapse
|
37
|
Munch Nielsen C, Gupta N, Knudsen LE, Holtermann A. Association of objectively measured occupational walking and standing still with low back pain: a cross-sectional study. Ergonomics 2017; 60:118-126. [PMID: 26968200 DOI: 10.1080/00140139.2016.1164901] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
OBJECTIVES This cross-sectional study investigated the association of objectively measured walking and standing still time at work with low back pain (LBP) intensity among blue-collar workers. DESIGN A cross-sectional study. METHODS 187 workers attached two accelerometers for diurnal standing still and walking measurements, which were categorised using tertiles. Workers' self-reported LBP intensity (scale 0-9) was categorised into low (0-5) and high pain (6-9). RESULTS Of the 187 workers, 17% reported a high level of LBP. Results of the multi-adjusted logistic regression analysis demonstrated a negative association between walking and high LBP intensity (OR 0.24 CL 95% 0.07 to 0.79). The results between standing still and high LBP intensity were mixed and non-significant. CONCLUSION Blue-collar workers who walk more at work tend to have low LBP. These results should be verified using objective measures in a prospective design. Practitioner Summary: Most studies on the association of occupational walking and standing still with LBP have used poor self-reported measures. This study investigated the association of objectively measured time spent walking and standing still at work with LBP among blue-collar workers. A significant negative association between walking and LBP was found. However, because of the cross-sectional design, these results should be further investigated in prospective studies.
Collapse
Affiliation(s)
- Camilla Munch Nielsen
- a Department of Musculoskeletal Disorders and Physical Workload , National Research Centre for the Working Environment , Copenhagen Ø , Denmark
| | - Nidhi Gupta
- a Department of Musculoskeletal Disorders and Physical Workload , National Research Centre for the Working Environment , Copenhagen Ø , Denmark
| | - Lisbeth E Knudsen
- b Department of Public Health , University of Copenhagen , Copenhagen K , Denmark
| | - Andreas Holtermann
- a Department of Musculoskeletal Disorders and Physical Workload , National Research Centre for the Working Environment , Copenhagen Ø , Denmark
| |
Collapse
|
38
|
Frederiksen M, Vorkamp K, Jensen NM, Sørensen JA, Knudsen LE, Sørensen LS, Webster TF, Nielsen JB. Dermal uptake and percutaneous penetration of ten flame retardants in a human skin ex vivo model. Chemosphere 2016; 162:308-314. [PMID: 27513551 DOI: 10.1016/j.chemosphere.2016.07.100] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2016] [Revised: 07/28/2016] [Accepted: 07/29/2016] [Indexed: 06/06/2023]
Abstract
The dermal uptake and percutaneous penetration of ten organic flame retardants was measured using an ex vivo human skin model. The studied compounds were DBDPE, BTBPE, TBP-DBPE, EH-TBB, BEH-TEBP, α, β and γ-HBCDD as well as syn- and anti-DDC-CO. Little or none of the applied flame retardants was recovered in either type of the receptor fluids used (physiological and worst-case). However, significant fractions were recovered in the skin depot, particularly in the upper skin layers. The primary effect of the worst-case receptor fluid was deeper penetration into the skin. The recovered mass was used to calculate lower- and upper-bound permeability coefficients kp. Despite large structural variation between the studied compounds, a clear, significant decreasing trend of kp was observed with increasing log Kow. The results indicate that the dermis may provide a significant barrier for these highly lipophilic compounds. However, based on our results, dermal uptake should be considered in exposure assessments, though it may proceed in a time-lagged manner compared to less hydrophobic compounds.
Collapse
Affiliation(s)
- Marie Frederiksen
- Danish Building Research Institute, Aalborg University, A.C. Meyers Vænge 15, 2450 Copenhagen SV, Denmark.
| | - Katrin Vorkamp
- Department of Environmental Science, Aarhus University, Frederiksborgvej 399, 4000 Roskilde, Denmark
| | - Niels Martin Jensen
- Department of Plastic and Reconstructive Surgery, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark
| | - Jens Ahm Sørensen
- Department of Plastic and Reconstructive Surgery, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 2100 Copenhagen Ø, Denmark
| | - Lars S Sørensen
- Danish Building Research Institute, Aalborg University, A.C. Meyers Vænge 15, 2450 Copenhagen SV, Denmark
| | - Thomas F Webster
- Department of Environmental Health, Boston University School of Public Health, 715 Albany St, Boston, MA 02118, USA
| | - Jesper B Nielsen
- Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 9B, 5000 Odense C, Denmark
| |
Collapse
|
39
|
Behbod B, Lauriola P, Leonardi G, Crabbe H, Close R, Staatsen B, Knudsen LE, de Hoogh K, Medina S, Semenza JC, Fletcher T. Environmental and public health tracking to advance knowledge for planetary health. Eur J Public Health 2016; 26:900. [PMID: 27744347 DOI: 10.1093/eurpub/ckw176] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | | | | | | | | | - Brigit Staatsen
- National Institute for Public Health and Environment, The Netherlands
| | | | - Kees de Hoogh
- Swiss Tropical and Public Health Institute, Switzerland.,University of Basel, Switzerland
| | | | - Jan C Semenza
- European Centre for Disease Prevention and Control, Sweden
| | | |
Collapse
|
40
|
Ayres Pereira M, Mandel Clausen T, Pehrson C, Mao Y, Resende M, Daugaard M, Riis Kristensen A, Spliid C, Mathiesen L, E. Knudsen L, Damm P, G. Theander T, R. Hansson S, A. Nielsen M, Salanti A. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog 2016; 12:e1005831. [PMID: 27556547 PMCID: PMC4996535 DOI: 10.1371/journal.ppat.1005831] [Citation(s) in RCA: 67] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2016] [Accepted: 07/28/2016] [Indexed: 02/07/2023] Open
Abstract
During placental malaria, Plasmodium falciparum infected erythrocytes sequester in the placenta, causing health problems for both the mother and fetus. The specific adherence is mediated by the VAR2CSA protein, which binds to placental chondroitin sulfate (CS) on chondroitin sulfate proteoglycans (CSPGs) in the placental syncytium. However, the identity of the CSPG core protein and the cellular impact of the interaction have remain elusive. In this study we identified the specific CSPG core protein to which the CS is attached, and characterized its exact placental location. VAR2CSA pull-down experiments using placental extracts from whole placenta or syncytiotrophoblast microvillous cell membranes showed three distinct CSPGs available for VAR2CSA adherence. Further examination of these three CSPGs by immunofluorescence and proximity ligation assays showed that syndecan-1 is the main receptor for VAR2CSA mediated placental adherence. We further show that the commonly used placental choriocarcinoma cell line, BeWo, express a different set of proteoglycans than those present on placental syncytiotrophoblast and may not be the most biologically relevant model to study placental malaria. Syncytial fusion of the BeWo cells, triggered by forskolin treatment, caused an increased expression of placental CS-modified syndecan-1. In line with this, we show that rVAR2 binding to placental CS impairs syndecan-1-related Src signaling in forskolin treated BeWo cells, but not in untreated cells. Plasmodium falciparum is the most deadly malaria parasite, causing more than 500,000 deaths each year. The parasite infects the host’s red blood cells. In placental malaria infected red blood cells accumulate in placenta. The parasite protein VAR2CSA mediates this adherence, which causes complications for both mother and child. VAR2CSA binds a carbohydrate chain termed chondroitin sulfate (CS). CS is not a well-defined biochemical entity but constitute a family of oligosaccharides which each have unique sulfation patterns. The CS binding VAR2CSA is attached to proteoglycans expressed on the surface of placental cells. While much work has gone into understanding the nature of VAR2CSA and its interaction with placental CS, the protein to which the placental CS is attached is not known. To further the understanding of the molecular pathology of PM we characterized the CSPG receptor that the parasites adhere to by defining the exact proteoglycan that carries the placental CS. We further investigated the molecular and cellular consequences of VAR2CSA binding to the receptor. This work provides novel insights into the pathology of placental malaria and the nature of the parasite receptor. This may aid development of strategies to treat or prevent placental malaria.
Collapse
Affiliation(s)
- Marina Ayres Pereira
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | - Thomas Mandel Clausen
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
- Vancouver Prostate Centre, Vancouver, BC, Canada
- * E-mail: (TMC); (AS)
| | - Caroline Pehrson
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | - Yang Mao
- Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark
| | - Mafalda Resende
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | | | | | - Charlotte Spliid
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | - Line Mathiesen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Lisbeth E. Knudsen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Peter Damm
- Department of Obstetrics, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Thor G. Theander
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | - Stefan R. Hansson
- Division of Obstetrics and Gynecology, Department of Clinical Sciences, Lund University Hospital, Lund University, Lund, Sweden
| | - Morten A. Nielsen
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
| | - Ali Salanti
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Copenhagen University Hospital, Denmark
- * E-mail: (TMC); (AS)
| |
Collapse
|
41
|
Brownbill P, Chernyavsky I, Bottalico B, Desoye G, Hansson S, Kenna G, Knudsen LE, Markert UR, Powles-Glover N, Schneider H, Leach L. An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancy. Reprod Toxicol 2016; 64:191-202. [PMID: 27327413 DOI: 10.1016/j.reprotox.2016.06.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2016] [Revised: 05/23/2016] [Accepted: 06/07/2016] [Indexed: 12/14/2022]
Abstract
The human placenta is a critical life-support system that nourishes and protects a rapidly growing fetus; a unique organ, species specific in structure and function. We consider the pressing challenge of providing additional advice on the safety of prescription medicines and environmental exposures in pregnancy and how ex vivo and in vitro human placental models might be advanced to reproducible human placental test systems (HPTSs), refining a weight of evidence to the guidance given around compound risk assessment during pregnancy. The placental pharmacokinetics of xenobiotic transfer, dysregulated placental function in pregnancy-related pathologies and influx/efflux transporter polymorphisms are a few caveats that could be addressed by HPTSs, not the specific focus of current mammalian reproductive toxicology systems. An international consortium, "PlaNet", will bridge academia, industry and regulators to consider screen ability and standardisation issues surrounding these models, with proven reproducibility for introduction into industrial and clinical practice.
Collapse
Affiliation(s)
- Paul Brownbill
- Maternal and Fetal Health Research Centre, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
| | - Igor Chernyavsky
- School of Mathematics, University of Manchester, Manchester, UK.
| | - Barbara Bottalico
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Lund University, Lund, Sweden,.
| | - Gernot Desoye
- Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
| | - Stefan Hansson
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Lund University, Lund, Sweden,.
| | | | - Lisbeth E Knudsen
- Department of Public Health, Faculty Of Health Sciences, University of Copenhagen, Denmark.
| | - Udo R Markert
- Placenta-Labor Laboratory, Department of Obstetrics, Friedrich Schiller University, D-07740, Jena, Germany.
| | - Nicola Powles-Glover
- Reproductive, Development and Paediatric Centre of Excellence, AstraZeneca, Mereside, Alderley Park, Alderley Edge SK10 4TG, UK.
| | - Henning Schneider
- Department of Obstetrics and Gynecology, Inselspital, University of Bern, Switzerland.
| | - Lopa Leach
- Molecular Cell Biology & Development, School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, UK.
| |
Collapse
|
42
|
Pehrson C, Mathiesen L, Heno KK, Salanti A, Resende M, Dzikowski R, Damm P, Hansson SR, King CL, Schneider H, Wang CW, Lavstsen T, Theander TG, Knudsen LE, Nielsen MA. Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malaria. Malar J 2016; 15:292. [PMID: 27230523 PMCID: PMC4881162 DOI: 10.1186/s12936-016-1342-2] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2015] [Accepted: 05/12/2016] [Indexed: 11/10/2022] Open
Abstract
Background Placental malaria occurs when Plasmodium falciparum infected erythrocytes sequester in the placenta. Placental parasite isolates bind to chondroitin sulphate A (CSA) by expression of VAR2CSA on the surface of infected erythrocytes, but may sequester by other VAR2CSA mediated mechanisms, such as binding to immunoglobulins. Furthermore, other parasite antigens have been associated with placental malaria. These findings have important implications for placental malaria vaccine design. The objective of this study was to adapt and describe a biologically relevant model of parasite adhesion in intact placental tissue. Results The ex vivo placental perfusion model was modified to study adhesion of infected erythrocytes binding to CSA, endothelial protein C receptor (EPCR) or a transgenic parasite where P. falciparum erythrocyte membrane protein 1 expression had been shut down. Infected erythrocytes expressing VAR2CSA accumulated in perfused placental tissue whereas the EPCR binding and the transgenic parasite did not. Soluble CSA and antibodies specific against VAR2CSA inhibited binding of infected erythrocytes. Conclusion The ex vivo model provides a novel way of studying receptor-ligand interactions and antibody mediated inhibition of binding in placental malaria. Electronic supplementary material The online version of this article (doi:10.1186/s12936-016-1342-2) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Caroline Pehrson
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
| | - Line Mathiesen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 1353, Copenhagen, Denmark
| | - Kristine K Heno
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Ali Salanti
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Mafalda Resende
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Ron Dzikowski
- Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University-Hadassah Medical School, 91120, Jerusalem, Israel
| | - Peter Damm
- Department of Obstetrics, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark
| | - Stefan R Hansson
- Division of Obstetrics and Gynecology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden
| | - Christopher L King
- Center for Global Health and Diseases, Case Western Reserve University and Veterans Affairs Medical Center, Cleveland, USA
| | - Henning Schneider
- Department of Obstetrics and Gynecology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Christian W Wang
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Thomas Lavstsen
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Thor G Theander
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Lisbeth E Knudsen
- Section of Environmental Health, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5A, 1353, Copenhagen, Denmark
| | - Morten A Nielsen
- Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen and at Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
| |
Collapse
|
43
|
Dusinska M, Boland S, Saunders M, Juillerat-Jeanneret L, Tran L, Pojana G, Marcomini A, Volkovova K, Tulinska J, Knudsen LE, Gombau L, Whelan M, Collins AR, Marano F, Housiadas C, Bilanicova D, Halamoda Kenzaoui B, Correia Carreira S, Magdolenova Z, Fjellsbø LM, Huk A, Handy R, Walker L, Barancokova M, Bartonova A, Burello E, Castell J, Cowie H, Drlickova M, Guadagnini R, Harris G, Harju M, Heimstad ES, Hurbankova M, Kazimirova A, Kovacikova Z, Kuricova M, Liskova A, Milcamps A, Neubauerova E, Palosaari T, Papazafiri P, Pilou M, Poulsen MS, Ross B, Runden-Pran E, Sebekova K, Staruchova M, Vallotto D, Worth A. Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST. Nanotoxicology 2016; 9 Suppl 1:118-32. [PMID: 25923349 DOI: 10.3109/17435390.2014.991431] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project ( www.nanotest-fp7.eu ) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed.
Collapse
Affiliation(s)
- M Dusinska
- Health Effects Laboratory-MILK, NILU - Norwegian Institute for Air Research , Kjeller , Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Andersen ZJ, Sram RJ, Ščasný M, Gurzau ES, Fucic A, Gribaldo L, Rossner P, Rossnerova A, Kohlová MB, Máca V, Zvěřinová I, Gajdosova D, Moshammer H, Rudnai P, Knudsen LE. Newborns health in the Danube Region: Environment, biomonitoring, interventions and economic benefits in a large prospective birth cohort study. Environ Int 2016; 88:112-122. [PMID: 26735349 DOI: 10.1016/j.envint.2015.12.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2015] [Revised: 12/07/2015] [Accepted: 12/10/2015] [Indexed: 06/05/2023]
Abstract
BACKGROUND The EU strategy for the Danube Region addresses numerous challenges including environment, health and socioeconomic disparities. Many old environmental burdens and heavily polluted areas in Europe are located in the Danube Region, consisting of 14 countries, with over 100 million people. Estimating the burden of environmental exposures on early-life health is a growing research area in Europe which has major public health implications, but the data from the Danube Region are largely missing. AIM This review presents an inventory of current environmental challenges, related early-life health risks, and knowledge gaps in the Danube Region, based on publicly available databases, registers, and literature, as a rationale and incentive for a new integrated project. The review also proposes the concept for the project aiming to characterize in utero exposures to multiple environmental factors and estimate their effect on early-life health, evaluate economic impact, as well as identify interventions with a potential to harness social norms to reduce emissions, exposures and health risks in the Danube Region. METHODS Experts in environmental epidemiology, human biomonitoring and social science in collaboration with clinicians propose to establish a new large multi-center birth cohort of mother-child pairs from Danube countries, measure biomarkers of exposure and health in biological samples at birth, collect centrally measured climate, air and water pollution data, conduct pre- and postnatal surveys on lifestyle, indoor exposures, noise, occupation, socio-economic status, risk-averting behavior, and preferences; and undertake clinical examinations of children at and after birth. Birth cohort will include at least 2000 newborns per site, and a subset of at least 200 mother-child pairs per site for biomonitoring. Novel biomarkers of exposure, susceptibility, and effect will be applied, to gain better mechanistic insight. Effects of multiple environmental exposures on fetal and child growth, respiratory, allergic, immunologic, and neurodevelopmental health outcomes will be estimated. Parent's willingness to pay for reducing health risks in children will be elicited by survey, while values of cost-of-illness will be gathered from literature and national statistics. Effects of risk reducing interventions will be examined. CONCLUSIONS The proposed project would provide novel estimates of the burden of early childhood diseases attributable to environmental exposures and assess health impacts of different intervention scenarios in the Danube Region, in an integrated approach combining human biomonitoring, epidemiological and social science research.
Collapse
Affiliation(s)
- Zorana J Andersen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014 Copenhagen, Denmark.
| | - Radim J Sram
- Institute of Experimental Medicine, AS CR Videnska 1083, 142 20 Prague 4, Czech Republic.
| | - Milan Ščasný
- Charles University in Prague, Environment Center, Jose Martiho 2, 162 00 Prague 6, Czech Republic.
| | - Eugen S Gurzau
- The Environmental Health Center, Busuiocului 58, 400240 Cluj Napoca, Romania.
| | - Aleksandra Fucic
- Institute for Medical Research and Occupational Health, Ksaverska c 2, 10000 Zagreb, Croatia.
| | - Laura Gribaldo
- EC DG Joint Research Centre, Institute for Health and Consumer Protection, TP 260, Via E. Fermi, 2749 21027 Ispra, Italy.
| | - Pavel Rossner
- Institute of Experimental Medicine, AS CR Videnska 1083, 142 20 Prague 4, Czech Republic.
| | - Andrea Rossnerova
- Institute of Experimental Medicine, AS CR Videnska 1083, 142 20 Prague 4, Czech Republic.
| | - Markéta Braun Kohlová
- Charles University in Prague, Environment Center, Jose Martiho 2, 162 00 Prague 6, Czech Republic.
| | - Vojtěch Máca
- Charles University in Prague, Environment Center, Jose Martiho 2, 162 00 Prague 6, Czech Republic.
| | - Iva Zvěřinová
- Charles University in Prague, Environment Center, Jose Martiho 2, 162 00 Prague 6, Czech Republic.
| | - Dagmar Gajdosova
- Regional Public Health Authority, Ipelska 1, 040 11 Kosice, Slovak Republic.
| | - Hanns Moshammer
- Institut Umwelt-Hygiene, Medical University of Vienna, Kinderspitalgasse 15, 1090 Vienna, Austria.
| | - Peter Rudnai
- National Center for Public Health, Budapest, Hungary.
| | - Lisbeth E Knudsen
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014 Copenhagen, Denmark.
| |
Collapse
|
45
|
Egsmose EL, Bräuner EV, Frederiksen M, Mørck TA, Siersma VD, Hansen PW, Nielsen F, Grandjean P, Knudsen LE. Associations between plasma concentrations of PCB 28 and possible indoor exposure sources in Danish school children and mothers. Environ Int 2016; 87:13-19. [PMID: 26638015 DOI: 10.1016/j.envint.2015.11.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/21/2015] [Revised: 11/07/2015] [Accepted: 11/08/2015] [Indexed: 06/05/2023]
Abstract
BACKGROUND Polychlorinated biphenyls (PCBs) are ubiquitously present in the environment and are suspected of carcinogenic, neurotoxic and immunotoxic effects. Significantly higher plasma concentrations of the congener PCB 28 occur in children compared to adults. Exposure in schools may contribute to this difference. OBJECTIVE To determine whether increased blood plasma concentrations of PCB 28 in Danish school children and mothers are associated with living in homes or attending schools constructed in the PCB period (1959-1977). METHODS PCB 28 was analyzed in plasma samples from 116 children aged 6-11years and 143 mothers living in an urban and a rural area in Denmark and participating in the European pilot project DEMOCOPHES (Demonstration of a study to COordinate and Perform Human Biomonitoring on a European Scale). In Denmark, PCBs were used in construction in the period 1950-1977, and year of construction or renovation of the homes and schools was used as a proxy for indoor PCB exposure. Linear regression models were used to assess the association between potential PCB exposure from building materials and lipid adjusted concentrations of PCB 28 in plasma, with and without adjustment for potential confounders. RESULTS Among the 116 children and 143 mothers, we were able to specify home construction period in all but 4 children and 5 mothers leaving 111 children and 138 mothers for our analyses. The median lipid adjusted plasma PCB 28 concentration was 3 (range: 1-28) ng/g lipid in the children and 2 (range: 1-8) ng/g lipid in the mothers. Children living in homes built in the PCB period had significantly higher lipid adjusted plasma PCB 28 concentrations compared to children living in homes built before or after the PCB period. Following adjustment for covariates, PCB 28 concentrations in children were 40 (95% CI: 13; 68) percent higher than concentrations of children living in homes constructed at other times. Furthermore, children attending schools built or substantially refurbished in the PCB period also had significantly higher (46%, 95% CI: 22; 70) PCB 28 concentrations compared to children attending schools constructed before or after the PCB period, while their mothers had similar concentrations. Adjustment for the most prevalent congener, PCB 153, did not change this effect of home or school construction. When both home and school construction year were included in the models, the increase in lipid adjusted plasma PCB 28 for children living in or attending schools from the PCB period was no longer statistically significant. The individual effect of home and school construction periods could not be evaluated further with the available data. CONCLUSION Our results suggest that PCB exposure in the indoor environment in schools and homes constructed during the PCB period may contribute significantly to children's plasma PCB 28 concentration. Efforts to minimize PCB exposure in indoor environments should be considered.
Collapse
Affiliation(s)
- Emilie Lund Egsmose
- Section of Environmental Health, Faculty of Health Sciences, University of Copenhagen, Denmark
| | - Elvira Vaclavik Bräuner
- Department of Construction and Health, Danish Building Research Institute, Aalborg University, Denmark
| | - Marie Frederiksen
- Department of Construction and Health, Danish Building Research Institute, Aalborg University, Denmark
| | - Thit Aarøe Mørck
- Section of Environmental Health, Faculty of Health Sciences, University of Copenhagen, Denmark
| | - Volkert Dirk Siersma
- The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Pernille Winton Hansen
- Section of Environmental Health, Faculty of Health Sciences, University of Copenhagen, Denmark
| | - Flemming Nielsen
- Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, Denmark
| | - Philippe Grandjean
- Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, Denmark
| | - Lisbeth E Knudsen
- Section of Environmental Health, Faculty of Health Sciences, University of Copenhagen, Denmark.
| |
Collapse
|
46
|
Graungaard AH, Siersma V, Lykke K, Ertmann RK, Knudsen LE, Mäkelä M. Maternal pain influences her evaluation of recurrent pain in 6- to 11-year-old healthy children. Acta Paediatr 2016; 105:183-90. [PMID: 26383986 DOI: 10.1111/apa.13216] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Revised: 05/19/2015] [Accepted: 09/11/2015] [Indexed: 11/29/2022]
Abstract
AIM Children with recurrent pain rely on their parents to acknowledge it. We compared pain reported by healthy children and their mothers, to evaluate their agreement, and also looked at the effect of maternal health on children's pain. METHODS This was a cross-sectional questionnaire-based survey in Danish public schools. The participants were 131 healthy children aged 6-11 years and their mothers. The main outcome measures were the prevalence of recurrent pain reported by the mother and child, agreements between their reports and any associations between the child's pain, socio-demographic characteristics and maternal health factors. RESULTS Recurrent pain was reported by nearly one-third (31%) of the children and their mothers. A quarter (25%) of the mother-child pairs disagreed on the existence of pain in the child, and a third (33%) disagreed on the frequency and duration. When the data were adjusted for child characteristics and socio-demographic parameters, mothers who had chronic pain were five times more likely to report frequent pain in their children than mothers without pain. This is a new finding. CONCLUSION Maternal health factors may influence her evaluation of her child's pain. Family health and pain behaviour should be considered when recurrent pain is suspected in a child.
Collapse
Affiliation(s)
- Anette Hauskov Graungaard
- Research Unit for General Practice and Section of General Practice; Department of Public Health; University of Copenhagen; Copenhagen Denmark
- The University Clinic of Primary Health Care; Copenhagen Denmark
| | - Volkert Siersma
- Research Unit for General Practice and Section of General Practice; Department of Public Health; University of Copenhagen; Copenhagen Denmark
| | - Kirsten Lykke
- Research Unit for General Practice and Section of General Practice; Department of Public Health; University of Copenhagen; Copenhagen Denmark
| | - Ruth Kirk Ertmann
- Research Unit for General Practice and Section of General Practice; Department of Public Health; University of Copenhagen; Copenhagen Denmark
| | - Lisbeth E. Knudsen
- Section of Environmental Health; Department of Public Health; University of Copenhagen; Copenhagen Denmark
| | - Marjukka Mäkelä
- Section of General Practice; Department of Public Health; University of Copenhagen; Copenhagen Denmark
- Finnish Office for HTA (FINOHTA); National Institute of Health and Welfare; Helsinki Finland
| |
Collapse
|
47
|
Pedersen M, Mendez MA, Schoket B, Godschalk RW, Espinosa A, Landström A, Villanueva CM, Merlo DF, Fthenou E, Gracia-Lavedan E, van Schooten FJ, Hoek G, Brunborg G, Meltzer HM, Alexander J, Nielsen JK, Sunyer J, Wright J, Kovács K, de Hoogh K, Gutzkow KB, Hardie LJ, Chatzi L, Knudsen LE, Anna L, Ketzel M, Haugen M, Botsivali M, Nieuwenhuijsen MJ, Cirach M, Toledano MB, Smith RB, Fleming S, Agramunt S, Kyrtopoulos SA, Lukács V, Kleinjans JC, Segerbäck D, Kogevinas M. Erratum: "Environmental, Dietary, Maternal, and Fetal Predictors of Bulky DNA Adducts in Cord Blood: A European Mother-Child Study (NewGeneris)". Environ Health Perspect 2016; 124:A12. [PMID: 26720407 PMCID: PMC4710585 DOI: 10.1289/ehp.124-a12] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
48
|
Exley K, Aerts D, Biot P, Casteleyn L, Kolossa-Gehring M, Schwedler G, Castaño A, Angerer J, Koch HM, Esteban M, Schindler BK, Schoeters G, Den Hond E, Horvat M, Bloemen L, Knudsen LE, Joas R, Joas A, Sepai O. Pilot study testing a European human biomonitoring framework for biomarkers of chemical exposure in children and their mothers: experiences in the UK. Environ Sci Pollut Res Int 2015; 22:15821-15834. [PMID: 26036586 DOI: 10.1007/s11356-015-4772-4] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Accepted: 12/03/2014] [Indexed: 06/04/2023]
Abstract
Exposure to a number of environmental chemicals in UK mothers and children has been assessed as part of the European biomonitoring pilot study, Demonstration of a Study to Coordinate and Perform Human Biomonitoring on a European Scale (DEMOCOPHES). For the European-funded project, 17 countries tested the biomonitoring guidelines and protocols developed by COPHES. The results from the pilot study in the UK are presented; 21 school children aged 6-11 years old and their mothers provided hair samples to measure mercury and urine samples, to measure cadmium, cotinine and several phthalate metabolites: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP), mono-ethyl phthalate (MEP), mono-iso-butyl phthalate (MiBP), mono-benzyl phthalate (MBzP) and mono-n-butyl phthalate (MnBP). Questionnaire data was collected on environment, health and lifestyle. Mercury in hair was higher in children who reported frequent consumption of fish (geometric mean 0.35 μg/g) compared to those that ate fish less frequently (0.13 μg/g, p = 0.002). Cadmium accumulates with age as demonstrated by higher levels of urinary cadmium in the mothers (geometric mean 0.24 μg/L) than in the children(0.14 μg/L). None of the mothers reported being regular smokers, and this was evident with extremely low levels of cotinine measured (maximum value 3.6 μg/L in mothers, 2.4 μg/L in children). Very low levels of the phthalate metabolites were also measured in both mothers and children (geometric means in mothers: 5OH-MEHP 8.6 μg/L, 5oxo-MEHP 5.1 μg/L, MEHP 1.2 μg/L, MEP 26.8 μg/L, MiBP 17.0 μg/L, MBzP 1.6 μg/L and MnBP 13.5 μg/L; and in children: 5OH-MEHP 18.4 μg/L, 5oxo-MEHP 11.4 μg/L, MEHP 1.4 μg/L, MEP 14.3 μg/L, MiBP 25.8 μg/L, MBzP 3.5 μg/L and MnBP 22.6 μg/L). All measured biomarker levels were similar to or below population-based reference values published by the US National Health and Nutrition Examination Survey (NHANES) and Germany's GerES surveys. No results were above available health guidance values and were of no concern with regards to health. The framework and techniques learnt here will assist with future work on biomonitoring in the UK.
Collapse
Affiliation(s)
- Karen Exley
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, Oxfordshire, OX11 0RQ, UK.
| | - Dominique Aerts
- Federal Public Service Health, Food Chain Safety and Environment, Brussels, Belgium
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, Brussels, Belgium
| | | | | | | | | | - Jürgen Angerer
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universitat Bochum (IPA), Bochum, Germany
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universitat Bochum (IPA), Bochum, Germany
| | - Marta Esteban
- Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Birgit K Schindler
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universitat Bochum (IPA), Bochum, Germany
| | - Greet Schoeters
- Environmental Risk and Health Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Elly Den Hond
- Environmental Risk and Health Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | | | - Louis Bloemen
- Environmental Health Science International, Hulst, Netherlands
| | | | | | | | - Ovnair Sepai
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, Oxfordshire, OX11 0RQ, UK
| |
Collapse
|
49
|
Joas A, Knudsen LE, Kolossa-Gehring M, Castano-Calvo A, Schoeters G. Human biomonitoring - special features of HBM and its synergies with other health information instruments? Eur J Public Health 2015. [DOI: 10.1093/eurpub/ckv173.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Langie SAS, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, Azqueta A, Bisson WH, Brown DG, Brunborg G, Charles AK, Chen T, Colacci A, Darroudi F, Forte S, Gonzalez L, Hamid RA, Knudsen LE, Leyns L, Lopez de Cerain Salsamendi A, Memeo L, Mondello C, Mothersill C, Olsen AK, Pavanello S, Raju J, Rojas E, Roy R, Ryan EP, Ostrosky-Wegman P, Salem HK, Scovassi AI, Singh N, Vaccari M, Van Schooten FJ, Valverde M, Woodrick J, Zhang L, van Larebeke N, Kirsch-Volders M, Collins AR. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis 2015; 36 Suppl 1:S61-88. [PMID: 26106144 DOI: 10.1093/carcin/bgv031] [Citation(s) in RCA: 119] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Genome instability is a prerequisite for the development of cancer. It occurs when genome maintenance systems fail to safeguard the genome's integrity, whether as a consequence of inherited defects or induced via exposure to environmental agents (chemicals, biological agents and radiation). Thus, genome instability can be defined as an enhanced tendency for the genome to acquire mutations; ranging from changes to the nucleotide sequence to chromosomal gain, rearrangements or loss. This review raises the hypothesis that in addition to known human carcinogens, exposure to low dose of other chemicals present in our modern society could contribute to carcinogenesis by indirectly affecting genome stability. The selected chemicals with their mechanisms of action proposed to indirectly contribute to genome instability are: heavy metals (DNA repair, epigenetic modification, DNA damage signaling, telomere length), acrylamide (DNA repair, chromosome segregation), bisphenol A (epigenetic modification, DNA damage signaling, mitochondrial function, chromosome segregation), benomyl (chromosome segregation), quinones (epigenetic modification) and nano-sized particles (epigenetic pathways, mitochondrial function, chromosome segregation, telomere length). The purpose of this review is to describe the crucial aspects of genome instability, to outline the ways in which environmental chemicals can affect this cancer hallmark and to identify candidate chemicals for further study. The overall aim is to make scientists aware of the increasing need to unravel the underlying mechanisms via which chemicals at low doses can induce genome instability and thus promote carcinogenesis.
Collapse
Affiliation(s)
- Sabine A S Langie
- Environmental Risk and Health Unit, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium, Health Canada, Environmental Health Sciences and Research Bureau, Environmental Health Centre, Ottawa, Ontario K1A0K9, Canada, Department of Pathology, Kuwait University, Safat 13110, Kuwait, Department of Experimental and Clinical Medicine, University of Firenze, Florence 50134, Italy, Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Pamplona 31009, Spain, Environmental and Molecular Toxicology, Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331, USA, Department of Environmental and Radiological Health Sciences/Food Science and Human Nutrition, College of Veterinary Medicine and Biomedical Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523-1680, USA, Department of Chemicals and Radiation, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway, Hopkins Building, School of Biological Sciences, University of Reading, Reading, Berkshire RG6 6UB, UK, Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA, Center for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna 40126, Italy, Human and Environmental Safety Research, Department of Health Sciences, College of North Atlantic, Doha, State of Qatar, Mediterranean Institute of Oncology, 95029 Viagrande, Italy, Laboratory for Cell Genetics, Vrije Universiteit Brussel, Brussels 1050, Belgium, Department of Biomedical Science, Faculty of Medicine and Health Sciences, University Putra, Serdang 43400, Selangor, Malaysia, University of Copenhagen, Department of Public Health, Copenhagen 1353, Denmark, Institute of Molecular Genetics, National Research Council, Pavia 27100, Italy, Medical Phys
| | - Gudrun Koppen
- Environmental Risk and Health Unit, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium, Health Canada, Environmental Health Sciences and Research Bureau, Environmental Health Centre, Ottawa, Ontario K1A0K9, Canada, Department of Pathology, Kuwait University, Safat 13110, Kuwait, Department of Experimental and Clinical Medicine, University of Firenze, Florence 50134, Italy, Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Pamplona 31009, Spain, Environmental and Molecular Toxicology, Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331, USA, Department of Environmental and Radiological Health Sciences/Food Science and Human Nutrition, College of Veterinary Medicine and Biomedical Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523-1680, USA, Department of Chemicals and Radiation, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway, Hopkins Building, School of Biological Sciences, University of Reading, Reading, Berkshire RG6 6UB, UK, Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA, Center for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna 40126, Italy, Human and Environmental Safety Research, Department of Health Sciences, College of North Atlantic, Doha, State of Qatar, Mediterranean Institute of Oncology, 95029 Viagrande, Italy, Laboratory for Cell Genetics, Vrije Universiteit Brussel, Brussels 1050, Belgium, Department of Biomedical Science, Faculty of Medicine and Health Sciences, University Putra, Serdang 43400, Selangor, Malaysia, University of Copenhagen, Department of Public Health, Copenhagen 1353, Denmark, Institute of Molecular Genetics, National Research Council, Pavia 27100, Italy, Medical Phys
| | - Daniel Desaulniers
- Health Canada, Environmental Health Sciences and Research Bureau, Environmental Health Centre, Ottawa, Ontario K1A0K9, Canada
| | - Fahd Al-Mulla
- Department of Pathology, Kuwait University, Safat 13110, Kuwait
| | | | - Amedeo Amedei
- Department of Experimental and Clinical Medicine, University of Firenze, Florence 50134, Italy
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Pamplona 31009, Spain
| | - William H Bisson
- Environmental and Molecular Toxicology, Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331, USA
| | - Dustin G Brown
- Department of Environmental and Radiological Health Sciences/Food Science and Human Nutrition, College of Veterinary Medicine and Biomedical Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523-1680, USA
| | - Gunnar Brunborg
- Department of Chemicals and Radiation, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway
| | - Amelia K Charles
- Hopkins Building, School of Biological Sciences, University of Reading, Reading, Berkshire RG6 6UB, UK
| | - Tao Chen
- Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
| | - Annamaria Colacci
- Center for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna 40126, Italy
| | - Firouz Darroudi
- Human and Environmental Safety Research, Department of Health Sciences, College of North Atlantic, Doha, State of Qatar
| | - Stefano Forte
- Mediterranean Institute of Oncology, 95029 Viagrande, Italy
| | - Laetitia Gonzalez
- Laboratory for Cell Genetics, Vrije Universiteit Brussel, Brussels 1050, Belgium
| | - Roslida A Hamid
- Department of Biomedical Science, Faculty of Medicine and Health Sciences, University Putra, Serdang 43400, Selangor, Malaysia
| | - Lisbeth E Knudsen
- University of Copenhagen, Department of Public Health, Copenhagen 1353, Denmark
| | - Luc Leyns
- Laboratory for Cell Genetics, Vrije Universiteit Brussel, Brussels 1050, Belgium
| | | | - Lorenzo Memeo
- Mediterranean Institute of Oncology, 95029 Viagrande, Italy
| | - Chiara Mondello
- Institute of Molecular Genetics, National Research Council, Pavia 27100, Italy
| | - Carmel Mothersill
- Medical Physics & Applied Radiation Sciences, McMaster University, Hamilton, Ontario L8S4L8, Canada
| | - Ann-Karin Olsen
- Department of Chemicals and Radiation, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway
| | - Sofia Pavanello
- Department of Cardiac, Thoracic and Vascular Sciences, Unit of Occupational Medicine, University of Padova, Padova 35128, Italy
| | - Jayadev Raju
- Toxicology Research Division, Bureau of Chemical Safety Food Directorate, Health Products and Food Branch Health Canada, Ottawa, Ontario K1A0K9, Canada
| | - Emilio Rojas
- Departamento de Medicina Genomica y Toxicologia Ambiental, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de México, México CP 04510, México
| | - Rabindra Roy
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
| | - Elizabeth P Ryan
- Department of Environmental and Radiological Health Sciences/Food Science and Human Nutrition, College of Veterinary Medicine and Biomedical Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523-1680, USA
| | - Patricia Ostrosky-Wegman
- Departamento de Medicina Genomica y Toxicologia Ambiental, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de México, México CP 04510, México
| | - Hosni K Salem
- Urology Department, kasr Al-Ainy School of Medicine, Cairo University, El Manial, Cairo 12515, Egypt
| | - A Ivana Scovassi
- Institute of Molecular Genetics, National Research Council, Pavia 27100, Italy
| | - Neetu Singh
- Centre for Advanced Research, King George's Medical University, Chowk, Lucknow 226003, Uttar Pradesh, India
| | - Monica Vaccari
- Center for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna 40126, Italy
| | - Frederik J Van Schooten
- Department of Toxicology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University, 6200MD, PO Box 61, Maastricht, The Netherlands
| | - Mahara Valverde
- Departamento de Medicina Genomica y Toxicologia Ambiental, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de México, México CP 04510, México
| | - Jordan Woodrick
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
| | - Luoping Zhang
- Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, CA 94720-7360, USA
| | - Nik van Larebeke
- Laboratory for Analytical and Environmental Chemistry, Vrije Universiteit Brussel, Brussels 1050, Belgium, Study Centre for Carcinogenesis and Primary Prevention of Cancer, Ghent University, Ghent 9000, Belgium
| | | | | |
Collapse
|